are missing
real investors
— but not LSI
Siemens, to the entrepreneurs behind Synchron, Auris Health,
and Neotract, decision-makers convene at LSI.
-
-(37).png)
John Viscogliosi
Sr. Managing Director
VB Enviro Care
---2025-07-01T181020.773.png)
Jon Root
General Partner
US Venture Partners
-(39).png)
Brook Byers
Founder
Kleiner Perkins
-(31).png)
Charles Warden
Managing Director
Versant Ventures
-(41).png)
Tak Cheung
Partner
NEA
-(42).png)
Geoff Pardo
General Partner
Gilde Healthcare
-(49).png)
Alan Cohen
General Partner
DCVC
-(44).png)
Christopher Shen
Partner
Novo Holdings
-(46).png)
Hanson Gifford
Managing Partner
The Foundry
-(50).png)
Murielle Thinard McLane
President and Managing Partner
Intuitive Ventures
-(46).png)
Antoine Papiernik
Chairman & Managing Partner
Sofinnova
-(48).png)
Chris Bischoff
Managing Director
General Catalyst
-(45).png)
Gwen Watanabe
Managing Director
H.I.G. Capital
-(44).png)
Greg Garfield
Senior Managing Director
KCK Medtech
-(48).png)
Andrew ElBardissi
Partner
Deerfield Management
-(52).png)
Rakesh J. Mehta
Partner
Centerview
.png)
Paul LaViolette
CEO & Co-Chairman, Managing Partner
Pulse Biosciences, SV Health
-(1).png)
Jay Watkins
Co-Chair & Partner
Sonder Capital
-(47).png)
Erich Wolff
Private Equity, Member of Management, Health & Life
Partners Investment Group
Samuel Levy
Founding Partner
Lauxera
-(3).png)
Duke Rohlen
CEO
Ajax Health
-
.png)
Thom Rasche
Managing Partner
Earlybird
-(30).png)
Alexander Morgan
Partner
Khosla Ventures
-(5).png)
Doug Solomon
Managing Director, Medical Technology
JP Morgan
-(6).png)
Rick Anderson
Chairman
Revival Healthcare Partners
-(7).png)
Neil Oberoi
Senior Managing Director
Guggenheim Securities
-(8).png)
John Ryan
Managing Director
Wells Fargo Strategic Capital
-(9).png)
Emily West
Managing Director
Goldman Sachs
-(10).png)
Lei Shi
Senior Partner
Eight Roads
-(11).png)
Dennis McWilliams
Managing Director
SANTÉ
-(12).png)
Marta-Gaia Zanchi
Founder & Managing Partner
Nina Capital
Vishal Gulati
Founder and Managing Partner
Recode Ventures
-(13).png)
Amy Salzhauer
Good Growth Capital
Founder & Managing Partner
Luc Marengere
TVM Capital Life Science
Managing Partner
-(14).png)
Frederik Groenewegen
415 Capital
Co-Founder & General Partner
-(15).png)
Kyle Dempsey
MVM Partners
Partner
-(16).png)
Adam Lubart
Perella Weinberg Partners
Managing Director
-(18).png)
William Dai
Founding Managing Partner
ShangBay Capital
-(19).png)
Maxwell Bikoff
Managing Director
Longitude Capital
-(20).png)
Ashley Friedman
Managing Director
Signet Healthcare Partners
Michael Wasserman
Partner & Chief Operating Officer
Elevage Medical
.png)
Caroline Gaynor
Partner
Lightstone Ventures
-
John Viscogliosi
Sr. Managing Director
VB Enviro Care
Jon Root
General Partner
US Venture Partners
Brook Byers
Founder
Kleiner Perkins
Charles Warden
Managing Director
Versant Ventures
Tak Cheung
Partner
NEA
Geoff Pardo
General Partner
Gilde Healthcare
-
Alan Cohen
General Partner
DCVC
Christopher Shen
Partner
Novo Holdings
Hanson Gifford
Managing Partner
The Foundry
Murielle Thinard McLane
President and Managing Partner
Intuitive Ventures
Antoine Papiernik
Chairman & Managing Partner
Sofinnova
Chris Bischoff
Managing Director
General Catalyst
-
Gwen Watanabe
Managing Director
H.I.G. Capital
Greg Garfield
Senior Managing Director
KCK Medtech
Andrew ElBardissi
Partner
Deerfield Management
Rakesh J. Mehta
Partner
Centerview
Paul LaViolette
CEO & Co-Chairman, Managing Partner
Pulse Biosciences, SV Health
Jay Watkins
Co-Chair & Partner
Sonder Capital
-
Erich Wolff
Private Equity, Member of Management, Health & Life
Partners Investment Group
Samuel Levy
Founding Partner
Lauxera
Duke Rohlen
CEO
Ajax Health
Thom Rasche
Managing Partner
Earlybird
Alexander Morgan
Partner
Khosla Ventures
Doug Solomon
Managing Director, Medical Technology
JP Morgan
-
Rick Anderson
Chairman
Revival Healthcare Partners
Neil Oberoi
Senior Managing Director
Guggenheim Securities
John Ryan
Managing Director
Wells Fargo Strategic Capital
Emily West
Managing Director
Goldman Sachs
Lei Shi
Senior Partner
Eight Roads
Dennis McWilliams
Managing Director
SANTÉ
-
Marta-Gaia Zanchi
Founder & Managing Partner
Nina Capital
Vishal Gulati
Founder and Managing Partner
Recode Ventures
Amy Salzhauer
Good Growth Capital
Founder & Managing Partner
Luc Marengere
TVM Capital Life Science
Managing Partner
Frederik Groenewegen
415 Capital
Co-Founder & General Partner
Kyle Dempsey
MVM Partners
Partner
-
Adam Lubart
Perella Weinberg Partners
Managing Director
William Dai
Founding Managing Partner
ShangBay Capital
Maxwell Bikoff
Managing Director
Longitude Capital
Ashley Friedman
Managing Director
Signet Healthcare Partners
Michael Wasserman
Partner & Chief Operating Officer
Elevage Medical
Caroline Gaynor
Partner
Lightstone Ventures
itself:
active investors
attend LSI
confirmed
to attend
LSI Europe ‘26?
investment banks, global strategics, and more in London this September.
-
_(41)-small.webp)
Kevin Lobo
Chair and CEO
Stryker
-(29)-small.webp)
Bernard Zovighian
CEO
Edwards
-(6)-small.webp)
Pat Beyer
CEO
Conmed
-(11)-small.webp)
Josep Ll Sanfeliu
Managing Partner
Asabys Partners
_(45)-small.webp)
Murielle Thinard McLane
President & Managing Partner
Intuitive Ventures
Antoine Papiernik
Managing Partner & Chairman
Sofinnova Partners
_(97)-small.webp)
Josh Makower
Professor of Medicine/Bioengineering, Director/Co-Founder, Stanford Mussallem Center for Biodesign
Venture Partner, Sofinnova Partners
_(61)-small.webp)
Chris Eso
VP, Global Head of Corporate and Business Development, M&A and Ventures
Medtronic
-(61)-small.webp)
Cécile Dupont
Partner
Sofinnova Partners
Hanson Gifford
Managing Partner
The Foundry, Inc.
Louise Warme
Corporate Venture Capital Director
We Venture Capital
Carey Smith
Founding Contrarian
Unorthodox Ventures
_(66)-small.webp)
Ed Rubin
Leader, Gore Ventures
W.L. Gore and Associates
-small.webp)
John White
Managing Director
KCK Medtech
_(94)-small.webp)
Mike Carusi
Managing Partner
Lightstone Ventures
_(2)-small.webp)
Hinke Malda
Vice President - Head of Corporate Venture Capital
Philips
_(76)-small.webp)
Dave Adair
Managing Partner, Co-founder
Solas BioVentures
_(47)-small.webp)
Luc Marengere
Managing Partner
TVM Capital
_(69)-small.webp)
Marc Subirats
General Partner
Nina Capital
Lærke Engkilde
Vice President
Novo Holdings
_(35)-small.webp)
Alessio Beverina
Founder & Managing Partner
Panakes Partners
-
_(14)-small.webp)
Catherine Mohr
President
Intuitive Foundation
_(46)-small.webp)
Raymond Cohen
Venture Partner
LifeScience Advisors and Wayfinder Advisors
Virginia Giddings
Vice President, Exploration
Edwards Lifesciences
-small.webp)
Kevin Cheng
Partner
MVM Partners
_-_2026-03-18T102941.233-small.webp)
Greg Garfield
Senior Managing Director
KCK Medtech
-(62)-small.webp)
Fernando Pacheco
Investment Director
Endeavour Vision
Yael Nir
Senior Director of Exploration
Edwards
Henry Zubaida
Investment Manager
Gilde Healthcare Partners B.V.
-(63)-small.webp)
Aneta Sottil
Partner
Andera Partners
Jan Engels
Senior Investment Manager
HTGF High-Tech Gründerfonds Management GmbH
-(13)-small.webp)
Gokce Gun
Analyst
Werfen S.A.
Daniel Allen
Principal
Unorthodox Ventures
David Belitz
Partner
Solas BioVentures
_(1)-small.webp)
Daniel Gilbertson
Sr. Corporate Development Director
Medtronic
Kate Jackson Hobbs
Corporate Development & Strategy Leader
Intuitive
Imran Hamid
Senior Director, Venture Investments
LivaNova
_(68)-small.webp)
Thom Rasche
Managing Partner
Earlybird Health Management GmbH & Co. KG
Kenny Nova
Managing Partner
NeoPrima Ventures
Mireia Angulo
Investment Director
Namarel Ventures
Claudio Nessi
Managing Director
Omega Funds
_(52)-small.webp)
Celia Hart
General Partner
Supernova Invest
-
Raphaël Wisniewski
Partner
Andera Partners
-(64)-small.webp)
Nir Goldenberg
Sr. Director, Business Development
Mayo Clinic
-(65)-small.webp)
Sylvain Sachot
Partner
Asabys Partners
Giovanni Carfi
Associate
Gyrus Capital
Maite Malet
Principal
Asabys Partners
Adam Rosenwach
Founding Managing Partner
Star51 Capital
Philip Kowalczyk
Chief Strategy and Corporate Development Officer
LivaNova
_(1)-small.webp)
Ehsan Jabbarzadeh
Venture Partner
IAG Capital Partners
_(63)-small.webp)
Srijoy Mahapatra
Divisional Vice President
Abbott
Janke Dittmer
General Partner, Head of European HealthTech Investments
Gilde Healthcare
Joe Jacobi
Co-Founder, Partner, & Chief Relationship Officer
Elevating Leadership Institute
_(10)-small.webp)
Susana Amorim Lopes
Investment Manager
Gilde Healthcare
_(34)-small.webp)
Diana Saraceni
Co-Founder and Managing Partner
Panakes Partners SGRSPA
-(66)-small.webp)
Matthew Abdel
Chair of the Surgical and Procedural Practice
Mayo Clinic
Laurent Pacheco
Managing Partner
International Family Office Alliance for Health
Olivier Litzka
Partner
Andera Partners
-(12)-small.webp)
Anne Osdoit
Partner, Sofinnova Partners - MD Start; CEO, Moon Surgical
Sofinnova Partners
Yannick Vancoppenolle
Partner
VIVES Partners
Philippe Durieux
Managing Partner
VIVES Partners
Mithi Thaya
General Partner
271.vc
_(91)-small.webp)
Michael Wang
Managing Director, GC Venture
Medtronic
-
_-_2026-03-18T095356.462-small.webp)
David Allen
Vice President | Corporate and Business Development
Medtronic
-(30)-small.webp)
Stefan Fischer
Managing Partner
TVM Capital
-(22)-small.webp)
Andrew Pieprzyk
Vice President, Strategic Development
Hologic
_(75)-small.webp)
Jinny Lee
VP, Exploration and Strategic Marketing
Edwards Lifesciences
_(43)-small.webp)
Caroline Gaynor
Partner
Lightstone Ventures
_(67)-small.webp)
John Yianni
Partner
Earlybird
_(69)-small.webp)
Christophe Van der Linden
Managing Director
WMC BV
_(57)-small.webp)
Robert (Bob) Schulz
Chief Partnership Officer
Nina Capital
_(56)-small.webp)
Anita Watkins
Managing Director
REX Health Ventures
_(49)-small.webp)
Joey Mason
Venture Partner
Claret Capital Partners
_(15)-small.webp)
Rachel Rea
Senior Director Business Development
Stryker
_(13)-small.webp)
Roman Rothaermel
Investment Principal
SCI Ventures
-(9)-small.webp)
Reinhard Krickl
Venture Partner
Hadean Ventures
_(16)-small.webp)
Frank Bulens
Partner
Xpand Partners
_-_2026-03-24T064727.478-small.webp)
Jake Goble
Innovation Leader, Medical Products Division
W.L. Gore and Associates
_(18)-small.webp)
Barak Singer
Executive VP, Head of Healthcare
The Trendlines Group
_-_2026-03-18T100545.501-small.webp)
Bibi Sattar Marques
Partner
BUENAVISTA EQUITY PARTNERS
_(4)-small.webp)
Philipp Lechner
Principal Venture Capital
TVM Capital
_(3)-small.webp)
Hubert Birner
Managing Partner
TVM Capital
_(58)-small.webp)
Kyle Sherrill
Investment Manager
Nina Capital
_(5)-small.webp)
Tyler Hayes
Investment Director
Philips
-
_-_2026-03-18T100734.168-small.webp)
Kinshuk Kocher
Investment Principal
Cedars-Sinai Technology Ventures
_(48)-small.webp)
Melissa Lezameta
Associate
Epidarex Capital
_(50)-small.webp)
Evan Castiglia
Partner
Thuja Capital Management
_(51)-small.webp)
Alexandre Cordier
Associate - Healthcare
Supernova
_(8)-small.webp)
Yahel Halamish
Partner
Nina Capital
_(55)-small.webp)
Boaz Lifschitz
Co-Founder & Managing General Partner
Peregrine Ventures
-small.webp)
Johannes Fischer
Partner
Wellington Partners
_(10)-small.webp)
Diego Serrano
Investor
Sofina
_(13)-small.webp)
Lisa Carmel
Chair Business Development
Mayo clinic
_(28)-(1)-small.webp)
Raf Roelands
Investment Director
HERAN Partners BV
_(12)-small.webp)
Filip Pintelon
Investment Director
Capricorn Partners
_(66)-small.webp)
Pieter Wijffels
Venture Partner
NLC Health Ventures
_(6)-small.webp)
Sebastian Anastassiou
Partner & Head of Investments
Nina Capital
_(19)-small.webp)
Andreas Wuepper
Director Investments Europe
Fresenius Medcial Care Ventures GmbH
_(25)-small.webp)
Karl Stoklosa
CEO
Precisis
_(53)-small.webp)
Lior Shahory
General Partner
Peregrine Ventures
_-_2026-03-18T094043.382-small.webp)
Yvonne Bokelman
Executive Director
MedtechWOMEN
_(59)-small.webp)
Fiorela Kapllanaj
Sr. Analyst
Nina Capital
_(34)-small.webp)
Raj Shah
CEO
GuideAI Health
_-_2026-03-18T093309.787-small.webp)
Marcin Golebicki
CEO and Founder
ReNavie Sensing
_(19)-small.webp)
Jochen Reinöhl
CEO
Coramaze Technologies
-
_(28)-small.webp)
Bart Bandy
Chief Executive Officer
Solenic Medical
_(31)-small.webp)
Ana Maiques
CEO & CoFounder
Neuroelectrics
_(29)-small.webp)
Alexis Peyroles
CEO
BetaGlue Therapeutics SpA
_(26)-small.webp)
Pri Hancock
CFO
Echopoint Medical
_(80)-small.webp)
Peter Fischer
CEO
Inkspace Imaging
_(33)-small.webp)
Enrique Vega
CEO
Azalea Vision
_(32)-(1)-small.webp)
George Kramer
Founder & CEO
NeoCor
_(30)-small.webp)
Regina Atim
Founder
Clinicians Touch ALLYVE
_(27)-small.webp)
Finbar Dolan
CEO
VERSONO Medical
-(25)-small.webp)
Roger Zickfeld
Managing Director
Weild & Co.
_(65)-small.webp)
Jason Wolfe
Business Leader - Gore Ventures (Sr Vice President)
W.L. Gore and Associates
_(64)-small.webp)
Timothy Still
Operating Advisor
Revival Healthcare Capital & TSTILL Enterprises
_(62)-small.webp)
Luc Starmans
Partner
Brightlands Venture Partners
_(11)-small.webp)
Edward Ruppel
Senior Associate
Nexus Neurotech Ventures
_-_2026-03-18T093612.281-small.webp)
Ken Nelson
Founder & Managing Partner
Nelson Jennings Ventures
_-_2026-03-18T090558.702-small.webp)
Tal Wenderow
Founding Managing Partner
Star51 Capital
-(27)-small.webp)
Marc Gliner
Managing Director
Fullstim
-small.webp)
Chris Church
Principal
BlackRock
-(1)-small.webp)
Kristopher Carver
Associate Director, Venture Capital
Boston Scientific
_(23)-small.webp)
Zeeshan Syedain
CEO
Vascudyne Inc
_-_2026-03-18T092859.728-small.webp)
John Santini
President & CEO
Vergent Bioscience
-
_(22)-small.webp)
Moises Barbera Ramos
Founder and CEO
CLARO Surgical
_(16)-small.webp)
Paul Sargeant
President & Chief Executive Officer
Circular Genomics
Marcel Both
CEO
PharmaSens AG
Jannis Fischer
CEO
Positrigo
_-_2026-03-18T105404.171-small.webp)
Lucas Decuypere
CEO
Allegro
_(24)-small.webp)
Rubén Molina
CEO & Co-Founder
INNITIUS
_(20)-small.webp)
Solveig Johannessen
CEO
Dova Health Intelligence
_(15)-small.webp)
Veronique Ameye
CEO
ElectraDx
_(13)-small.webp)
Sean Morris
President & CEO
Amplifi Vascular
_(5)-small.webp)
Christopher Lee
Co-Founder & CEO
HapticHeart Solutions, Inc.
Lloyd Diamond
CEO
Nitinotes
Will Mauldin
CEO
RIVANNA
_(4)-small.webp)
Bertrand Moal
CEO
DESKi
-(23)-small.webp)
Tonya Dowd
EVP Corporate Development
PRIA Healthcare
-(2)-small.webp)
Francis White
CEO
Heart Biotech Ltd
Malin Nilsson
CEO
Inossia
Thomas Weindl
CEO & Co-Founder
OLI
Christopher Carlton
Chairman and CEO
Accure Acne
_(33)-small.webp)
Hamed Hanafi
CEO
NovaResp Technologies Inc
_(1)-small.webp)
Manios Dimitrakakis
CEO
Panda Surgical
Gunter Trojandt
Managing Director
MDA - Medical Decision Alliance GmbH
-
_(8)-small.webp)
Marc Zemel
CEO
Retia Medical
_(7)-small.webp)
Christopher Gleason
President & CEO
Moximed
_(3)-small.webp)
Laura Becerra-Fajardo
CEO
FORESEE MedTech
_(6)-small.webp)
Tushar Sharma, PhD
CEO & Founder
Vivifi Medical Inc
-small.webp)
Nitzan Hirsh
Co-Founder and CEO
LuSeed Vascular
_(37)-small.webp)
Koen van Breugel
Investment Director
Coronet Ventures
_(39)-small.webp)
Fabian Ngo
Chief Strategy Officer
CathWorks
_(40)-small.webp)
Natalie Sickler
Chief Business Officer
CathWorks
_(42)-small.webp)
Michael Mandel
President
T45 Labs
_(44)-small.webp)
Kristien Esser
CEO
GS Capital Connect
_(54)-small.webp)
Emile Jones
EMEA Manager
Uniphar Logistics
_(7)-small.webp)
Aline Noizet
Community Manager
Nina Capital
_(17)-small.webp)
Evan Melrose, MD
CEO
Elevage Medical-Patient Square Capital
_(21)-small.webp)
Agata Guilherme
Experiential Marketing Specialist - Events
Medidata
Scott Huennekens
Chairman
Front Foot Ventures
Nadim Yared
Chairman, CEO
Encora Therapeutics
Michael Blue
President & CEO
HistoSonics
Lee Fleisher
CEO
Rubrum Advising
_(2)-small.webp)
Robert Kieval
President and Chief Executive Officer
Arctx Medical, Inc.
-small.webp)
Yana Reshetnyak
CEO
CleanMargin
Menachem Genut
Co-Founder & Chief Scientific Officer
YOPI
-
Christos Bergeles
Founder and CEO
Revitalise
_(4)-small.webp)
Jeremy Wheeler
CEO
BIOCAPTIVA LTD
_(9)-small.webp)
Maria Artunduaga
Founder & CEO
Samay
_(17)-small.webp)
Edouard Fonck
CEO
Cairdac
Dr. ir. Christoff Heunis
CEO
Flux Robotics B.V.
Vincent Legay
General Manager, EMEA Region
NAMSA
Deepak Sahu
Managing Director
Trinity Life Sciences
_(62)-small.webp)
Joe Mullings
Chairman & CEO
The Mullings Group Companies
_(38)-small.webp)
Mike Feher
Co-Founder, Chief Financial Officer
NovoMed
_(51)-small.webp)
Alyssa Howard
Vice President, Business Development
MCRA
Joshua Eckelberry
Principal
Solas BioVentures
_(1)-small.webp)
Bryant Grigsby
CEO
PDV MedTech
Barry Grossman
Partner
Ellenoff Grossman & Schole LLP
_(74)-small.webp)
Sabing Lee
Partner
Knobbe Martens, Partner
Yuval Mandelbaum
CEO
Discure Technologies
David Hochman
CEO
Orchestra BioMed, Inc.
_-_2026-03-18T101300.225-small.webp)
Ramin Mousavi
Founder, Chairman & CEO
NovoMed PARTNERS
_(85)-small.webp)
Roger Brooks
Founder, CEO, C-suite Executive Search
RBrooks Group
Henk Westendorp
Venture Partner, Lead Surgery, Head of Clinical Expertise
NLC Health Ventures
Lars Olthof
Investment Director & Head of Venture Finance
NLC Health Ventures
Kristin Duffey
Sr. Conferences & Events Specialist
Veranex
-
Adam Saltman
Chief Medical Officer
NAMSA
Deepak Sahu
Managing Director
Enam Holdings
Carolina Aguilar
CEO & Co-Founder
INBRAIN Neuroelectronics
_(3)-small.webp)
Steve West
Managing Director
Healthliant Ventures @ Tanner Health
Mathieu RIMAUD
CEO
Twinsight
-small.webp)
Anna Nikitina
Business Development and Legal Advisor
Clinical Accelerator LTD
_(9)-small.webp)
Hannah Tapsell Chapman
Investor
Mercia Ventures
Euan Thomson
Venture Partner
Precision Life Science Partners
Chaim Lotan
Chief Innovation Officer
Hadassah Hebrew University Medical Center & SmartValves
_(14)-small.webp)
Colby Holtshouse
CEO
May Health
Bruce Ramshaw
CMIO
Caresyntax
_(8)-small.webp)
Gautam Kainth
Partner
TCP Health Ventures
-small.webp)
Elliot Street
CEO
Inovus Medical
_(65)-small.webp)
Arthur (Yen Yu) Chen
Managing Partner (執行合夥人)
BE Health Ventures
_(6)-small.webp)
David Caumartin
CEO
Rebrain
_(2)-small.webp)
Joana Cartocci
Cofounder & COO
Robeaute
_(20)-small.webp)
Alexander Marcantonio
Partner
Madryn Asset Management
-small.webp)
Ivanny Franklin
Managing Partner
MedSight Capital
-small.webp)
Elisenda Bonet Carné
CEO & Co-founder
fetaLife Technologies
_(12)-small.webp)
Salma Al Zu'bi
Investment Principal
Hikma Pharmaceuticals
Christopher Campbell
Managing Partner
Precision Life Science Partners
-
Robert Ward
MedTech IP Attorney
Greenberg Traurig LLP
_(5)-small.webp)
Christopher Morton
Business Executive and CEO (Founder)
ELEM Biotech
Bill Little
VP Corporate Development & Strategy
Orchestra BioMed
-small.webp)
Roger Assaker
CEO
MDsim
Chris Bolten
MedTech IP Attorney
Greenberg Traurig, LLP
_(11)-small.webp)
John Propst
Managing Partner
Ground Effect Ventures
Sanjay Kakkar
CEO
Tensive
Maurits Huigen
CEO
Gilbert
Tristan Smith
Principal
Unorthodox Ventures
-small.webp)
Lewis Kilongo
Principal
Unorthodox Ventures
Ryan Kaeding
Managing Director
Trinity Capital
Meni Iamberger
COO
SmartValves
Shy Zyman
Chief Executive Officer
Cell-Lipo
Damé Medarski
COO
GS Capital Connect
Hilla Benpazi
Founder & CEO
Avertto Medical LTD
Luca Ravagnan
CEO
WISE SpA
Shola Oyewole
Vice President - Digital Innovation
United Therapeutics Corp
Scott Whitaker
President & CEO
AdvaMed
Jingbo Zhai
General manager
HiMed Angel Investment Co., Ltd.
Gurpreet Singh
CEO
Respiree
Barry McCann
CEO & Founder
NUA Surgical Ltd
-
Manoj Bhargava
Partner
Sidley Austin
_(2)-small.webp)
Martin Deterre
CEO
Theraclion
Mathias Bouzereau
Senior Business Development Director, International
Pulnovo
Carlos Navarrete
Junior Business Developer
Catalonia Health
François Rosenfeld
Partner
Mérieux Equity Partners
Ariane De Marcillac
Associate - HealthTech
Gilde Healthcare Partners B.V.
Dan Azagury
Clinical Advisor
Sonder Capital
Emma Heckenberg
Analysts
Solas BioVentures
Haruka Fujita
Business Development Manager
Teijin Holdings Europe B.V.
El Nouchi Elisa
Senior VC Associate - Life Sciences
Bpifrance Investissement
Sonia Martinez Arca
Co-founder and CEO
Batea Oncology
Yuriy Onyskiv
Principal, Ventures
Orlando Health Ventures
Anders Lykke Iversen
Senior Associate
Novo Holdings
Eric Tansky
Managing Director
Oppenheimer
Sebastian Kronmueller
Senior Vice President, Head of Strategy and Ventures
Philips
Jian Luo
Business Development, Sr. Director, Greater China
BD
_(79)-small.webp)
Mohamad Alkhouli
Vice Chair for Strategic Partnerships
Mayo Clinic
Kristoff Goson
CEO
Pixee Medical
Adam Gridley
CEO
Vergent Bioscience
Arash Dodge
CEO
Haermonics BV
_(11)-small.webp)
Pablo Fernández
CEO
Polimerbio
-
Louis De Lillers
CEO
CorWave
Hamzeh Abdul Hadi
Senior Principal
Angelini Ventures
Sai Abhilash Lingala
Associate Director
Global Innovation Hub (Global HealthX)
Yvette Lu
Venture Partner
BE Health Ventures
Maya Misra
Senior Analyst
Angelini Ventures
M. Shane Ray
CEO and CCO
Hemanext, Inc.
-(1)-small.webp)
Margot Huysmans
Analyst
HERAN Partners II BV
_(3)-small.webp)
Aswin Hoffmann
EiR / Co-Founder
BEAMRION
_(4)-small.webp)
Peter Stalmans
Head of Clinic - Kliniekhoofd
UZ Leuven
_(5)-small.webp)
Robert King
Partner
1540 Ventures, LLC
Alexandra Abreu
VC
Angelini Ventures
-small.webp)
Ping Li
Regulatory, Government Affairs & Market Access, VP, Greater China
Becton Dickinson Medical Devices (Shanghai) Co., Ltd
Ainhoa Manterola Solans
Managing Director
Sofina
_(3)-small.webp)
Gonzalo Rubio Paris
Board Member
Sprim Global Investments
-small.webp)
James Deng
Senior Vice President
Becton Dickinson (BD)
Julien Brohan
Director, Medtech Ventures
Cedars-Sinai Technology Ventures
-(3)-small.webp)
Melissa Muller
Founder & Principal Consultant
Muller Advisory Company
Sofia Spjuth
VP Clinical Affairs, Europe
Veranex
Pablo Morales
Chief Medical Officer
Veranex
Cas Dercksen
Managing Partner
SALIMANDER
_(31)-small.webp)
Alex Joseph
Chief Executive Officer
Microsure
-
_(3)-small.webp)
Simon Mifsud
Chief Executive Officer
Garland Surgical
_(4)-small.webp)
Martin French
CEO
Carelight
_(6)-small.webp)
Joel Krupa
Chief Academic Officer
Agents of Discovery
_(29)-small.webp)
Scott Xiao
Co-Founder and CEO
Luminopia
_(7)-small.webp)
Dr. Tim Kaufmann
Founder and Chairman
LifeShield Medical
Dr. Erland Hermansen
Orthopedic Surgeon
NAMSA
_(5)-small.webp)
Aidan Mulloy
Founder and CEO
Eclipse Medical
_(10)-small.webp)
Rudolf Schulze Vohren
Co-Founder and CEO
Nano4Imaging
_(11)-small.webp)
Steve Motes
CEO
Tulyp Medical
_(12)-small.webp)
Maria Leiloglou
CEO
Enacuity
-(9)-small.webp)
Miguel Luengo-Oroz
CEO & Founder
Spotlab.ai
_(8)-small.webp)
Mathieu PIERONNE
Director
Andera Partners
Antonio Limatola
Senior Associate
Asabys Partners
_-_2026-03-19T085801.309-small.webp)
Bryan Lord
CEO
Pristine Surgical
Joseph Heanue
CEO
1540 Ventures
_-_2026-03-18T104105.532-small.webp)
Weronika Michaluk
MedTech Practice Lead
HTD
JCris Salinas
Senior VP
Medidata Solutions
Anna Hildebrand
Inaugural Principal
Star51 Capital
Eliot Horowitz
Founder & CEO
Viam
_(58)-small.webp)
Edwin Lindsay
Managing Director
CS Lifesciences
Tom Farr
Executive Search Consultant
The Mullings Group Companies
-
_(11)-small.webp)
David Chersky
VP of Strategic Sales
PDV MedTech
Jacob McLaughlin
CEO
New to Medical Device Sales
-small.webp)
Indraneel Bardhan
Founder and Partner
EOS Intelligence
_(67)-small.webp)
Pall Johannesson
Executive Vice President, Europe
Greenlight Guru
Suzie Bangle
Head of Medical Device
Barrington James
Lauren Sirek
Manager, Business Development & Marketing
PRIA Healthcare
_(9)-small.webp)
Rachel Knutton
CEO
Alluvia Studio
_(39)-small.webp)
Souvik Paul
CEO & Founder
Aurie
_(28)-small.webp)
Yuval Shklarsh
Founder & CEO
Kudu Med
_(14)-small.webp)
João Curado
CEO
Flomics Biotech
_(40)-small.webp)
Nahum Ferera
Co-Founder & CEO
EyeYon Medical
_(41)-small.webp)
Nadav Agian
CEO
Append Medical
_(42)-small.webp)
Michael Behr
CEO
Prolifagen
_(43)-small.webp)
Alexa Buck
Co-Founder
PACATIS
Menachem Genut
Co-Founder & Chief Scientific Officer
YOPI Technologies R&D LTD
_(44)-small.webp)
Simone Pollano
Co-founder & Investor Relations Officer
CardYograft
Todd Pope
Senior Partner
Revival Healthcare Capital
-small.webp)
Daniel Rose
CEO
Endovascular Engineering
_(7)-small.webp)
Nadim Yared
Founder
Antibes Ventures
_(1)-small.webp)
Nacho Abia
CEO
Grifols
Amir Gross
CEO Cardiovalve
SmartValves
-
-(5)-(3)-small.webp)
Addie Harris
Partner
Precision Life Science Partners
Euan Thomson
Venture Partner
1955 Capital
_(26)-small.webp)
Henry Peck
Chief Business Officer
LSI
Prashant Chopra
Founding CEO
Petal Surgical
-small.webp)
Nicholas Theodore
Co founder and Board Member
Petal Surgical
_(51)-small.webp)
Alexandre Cordier
Associate - Healthcare
Supernova Invest
Ileana Lindeman
Venture Partner, Orthopedics, Spine & Surgery
NLC Health Ventures
-small.webp)
Leonhard Riehle, MD
Co-Founder & CMedO
Noah Labs
-small.webp)
Olivier Taelman
CEO
Nyxoah
_(40)-small.webp)
John Schindler
Co-Founder & CEO
Liquet Medical Inc.
Joan Grasas
CEO
Debios Diagnostics
-small.webp)
Jay Kapoor
Business Development Lead
Sealantium Medical
Wolfgang Kintzel
Co-CEO & CSO
PreciPoint
Frank K. de Gioia
CEO
Collin Robotics
-small.webp)
Sanjay Shrivastava
CEO
Innova Vascular, Inc.
_(2)-small.webp)
Ohad Arazi
President and CEO
Subtle Medical
_(12)-small.webp)
Michael Gürtler
Chief Commercial Officer
RSP Systems A/S
_(11)-small.webp)
Tim Lawrie
CEO & Founder
Projectus Consulting
-(27)-small.webp)
Jordi Martorell
CEO & Co-Founder
Aortyx
-small.webp)
Eliane Schutte
CEO
Xeltis
_(10)-small.webp)
Diego Serrano
Investor
Sofina Group
-
_(60)-small.webp)
Marta G. Zanchi
Founder & Managing Partner
Nina Capital
Harnik Shukla
Partner
Knobbe Martens
_(13)-small.webp)
Laura Yecies
CEO
Osteoboost Health
_(14)-small.webp)
Magnus Jensen
CEO & Co-Founder
ClariDX
_(3)-small.webp)
Jonas Steinhäuser-Meerz
CEO & Co-Founder
NGScopes
_(10)-small.webp)
Morgan Mills
Senior Director
FloodGate Medical
_(2)-small.webp)
Francis White
CEO
Heart Biotech Holdings
Mark Bouw
Founder & CEO
Straterra Australia
_(32)-small.webp)
George Kramer
CEO
Neocor Medical Devices
Etienne Nichols
Head of Partnerships
Greenlight Guru
_(56)-small.webp)
Anita Watkins
Managing Director
UNC Health Ventures
_(23)-small.webp)
Maxwell Munford
CEO & Founder
OSSTEC
_(25)-small.webp)
Juan Alcantara Morales
CEO
Nuubo
_(16)-small.webp)
Gregor Strobbe
Founder CEO
Clouds of Care
Jessica Achtsam
Partner
Knobbe Martens
_(16)-small.webp)
Omid Akhavan
Managing Director
Anthro Ventures
Thomas Weindl
CEO & Co-Founder
OLI Technologies
Bill Marks
Chief Clinical Officer
Paradromics
_(19)-small.webp)
Andreas Wuepper
Director Investments Europe
Fresenius Medical Care Ventures GmbH
_(4)-small.webp)
Carl Daintree
CEO
QV Bioelectronics
_(13)-small.webp)
Rotem Kopel, PhD
CEO & Co-Founder
ABILITY Neurotech
-
_(21)-small.webp)
Vili Kostamo
Medical doctor, CEO, Co-Founder
MedicubeX
Patrick Pestalozzi
CEO
Abionic
_(20)-small.webp)
Ula Rustamova
CEO & Co-Founder
Level Zero Health
Christos Bergeles
CEO
Revitalise / King's College London
Maurits Huigen
CEO
Gilbert Group B.V.
_(4)-small.webp)
Carl Daintree
CEO
QV Bioelectronics
_(44)-small.webp)
Simone Pollano
General Manager Operations Europe
Cardyograft srl.
_(40)-small.webp)
Nahum Ferera
CEO & Co-Founder
EyeYon Medical Ltd.
_(5)-small.webp)
Carlos Bremer
Chief Strategy Officer
brain4care
-small.webp)
Darren Sherman
Founder & COO
Orchestra BioMed
-small.webp)
Michael Ebner
CEO & Co-Founder
Hypervision Surgical
-small.webp)
Hunt Henrie
CBO
Tissium
-small.webp)
Sarah Van Hellenberg Hubar-Fisher
CEO
Bioretec Ltd
-small.webp)
Zoar Engelman
CEO
Axon Therapies
_(8)-small.webp)
Chris Lear
Chief Strategy Officer
Prometheus Therapeutics
_(13)-small.webp)
Mike Connolly
CEO
Healionics Corp.
_(14)-small.webp)
Deniz Ozturk
VP, In Silico Technologies
Medividia
_(12)-small.webp)
David Jacques
CEO
Sonata Medtech
_(15)-small.webp)
Julien Penders
Co-Founder & COO
Bloomlife
_(16)-small.webp)
Juan Abascal
CEO & Founder
ABANZA
-small.webp)
Tony Kypreos
Entrepreneur in Residence
London Institute for Healthcare Engineering
-
_(4)-small.webp)
Rik Kielman
CEO
Implican
_(5)-small.webp)
Chris Hordijk
Founder/CEO
Surgical Reality
_(6)-small.webp)
Joel Krupa
CAO
Agents of Discovery Inc.
_(10)-small.webp)
Connor Keegan
Vice President
RBrooks Group Inc.
Robin Rump
Founder and CTO
Alpha Sophia
_(11)-small.webp)
Yi-Kai Lo
CEO
ANEUVO
Nicolás Barabino
CEO
ADCORPUS MEDTECH S.L.
-(11)-small.webp)
Andrés Vásquez Quintero
CEO/CTO & Co-Founder
Azalea Vision
Amr Salahieh
CEO
Shifamed
-small.webp)
Mariam Maghribi
Chief Business Officer
Atia Vision
-small.webp)
Kavi Vyas
Chief Commercial and Clinical Officer
Akura Medical
-small.webp)
Mano Iyer
Venture Partner
Sofinnova Partners
-small.webp)
Lars Kongsbak
CEO
Axithra
_(12)-small.webp)
Michal Jaworek
CEO & Co-Founder
Approxima
-small.webp)
Jeongwon Lee
CTO
Impact Korea Co., Ltd.
-small.webp)
David Gascoigne
CEO
Segmed
-small.webp)
Roger Johnston
CEO
Axial3D
-small.webp)
Jerome Marzinski
CEO
OxSonics
-small.webp)
Marcus Gerhardt
CEO & Co-Founder
Blackrock Neurotech
-small.webp)
Dr. Margaret Kalmeta
CEO
Rapid Nexus NWS
-small.webp)
Stéphane Corp
Co-Founder & CEO
DeepPulseNeuro
-
-small.webp)
Ludwig Gutzweiler
CTO & Managing Director
Dermagnostix
-small.webp)
Sofia Bertling
CEO
Utilizer
-small.webp)
Maraim Maghribi
Chief Business Officer
Shifamed/Tioga Cardiovascular
Greg Topalian
Chairman
Opus Origin
Lily Chen
MedTech Advisor and Limited Partner
Nina Capital
Desiree Hanson
President
Opus Origin
Megan MacDonagh
Vice President
Ally Bridge
Rafael Beyar
Professor Emeritus, Medicine and Biomedical Engineering, Technion
Alive and ICI
Raj Airey
Founding partner
Convergence Partners
Ineke Cazander
Principal
Invest-NL
Drew Burdon
Partner
EQT Partners
Eduard Hotsul
Principal - Strategy & BD - Eurasia
Medtronic International Trading Sarl
Ian Purdy
Senior Vice President, Regulatory Affairs & Quality Assurance
Purdy Healthtech Intnl
Thomas Serena
CEO and Medical Director
SerenaGroup, INC
_(9)-small.webp)
Eric Schantz
Principal Business Development Associate
Medtronic
-small.webp)
Christian Rybak
Partner/Shareholder
Greenberg Traurig
Redd Warburton
Co Founder
Scientia Talent
-small.webp)
Ahmed Elmouelhi
President and CEO
TRiCares
Stefan Pilz
CEO
HighLife SAS
-small.webp)
Stacey Pugh
CEO
Endogenex
_(6)-small.webp)
Kregg Koch
US Patent Attorney
Knobbe Martens
-
Glenn Stiegman
Senior Vice President, Clinical & Regulatory Affairs
MCRA
Michael Anselmo
VP of Reimbursement, Health Economics and Market Access
MCRA
_(5)-small.webp)
Abigail Allen
Vice President, Clinical Affairs
MCRA an IQVIA business
-small.webp)
Kei Müller
CEO
Ebenbuild
_-_2026-03-18T104105.532-small.webp)
Weronika Michaluk
MedTech Practice Lead
HTD Health
-small.webp)
Boris Pasche
Co-founder and Member
TheraBionic
-small.webp)
Toon Overbeeke
Co-Founder & CEO
Vitestro
-small.webp)
Claudia Rodiera, MD, PhD, EMBA
Co-Founder & Chief Medical Officer
Cufftech
-small.webp)
Shirish Joshi
CEO & Founder
Joshi Innovations
-small.webp)
Stefania Riboldi
Chief Technology Officer
Dialybrid
-small.webp)
Shamus Husheer
CEO
Heartfelt Technologies
-small.webp)
Theo Ruers
Co-founder and CEO
Juvant Medical
-small.webp)
Tom Moore
President & CEO
Minze Health
Mathias Bouzereau
Senior Business Development Director, International
Pulnovo Medical
_(3)-small.webp)
Simon Mifsud
CEO & Co-Founder
Garland Surgical Ltd
-small.webp)
Harlee Sorkin
CEO
InterShunt
-small.webp)
Carol Stafford
Client Executive - Medical Device & Diagnostics EMEA
Medidata
_(6)-small.webp)
Pawel Buszman
CEO
I4HV
-small.webp)
Jonas Funk
Manager Director
L.E.K. Consulting
-small.webp)
Houman Homayoun
Co-Founder & CEO
HealtheTile Technologies, Inc.
-small.webp)
Adrian Whitford
President
Invenio Imaging
-
_(9)-small.webp)
Sascha Berger
Senior Advisor
Aescuvest Capital Partners
Omar Khateeb
CEO
MarketCraft
Ryan Wade
Principal
Wayfinder Advisors and LifeScience Advisors
_(11)-small.webp)
Konrad Dobschuetz
Chief Strategy Officer
McGinley Orthopedics
-small.webp)
Elena Lovo
Head of EMEA Life Sciences, Innovation Economy
JP Morgan
_(70)-small.webp)
Chen Levin
Co-Founder and CEO
Earendel Medical
Brian Liles
Executive Vice President
CSSI - Cost Segregation Services
Brendan Marrinan
Head of Business Development
Innovative Catheter Solutions
Philip Taillieu
Co-founder - CEO
Cascador/moveUP
Chris Raphaely
Co-Chair, Health Care & Life Sciences Practice
Cozen O'Connor
-small.webp)
Duncan Keeble
Founder & Managing Director
OxDevice Medical
-small.webp)
Nils De Koff
Managing Director
LIMIS
-small.webp)
Tanja Danner
CEO & Founder
Prenaital
-small.webp)
Scott Verner
CEO
Neuroview Technology
-small.webp)
Rob Taft
CEO
ReLAAx Medical
-small.webp)
Loulia Kassem
Co-Founder & CEO
Rea Diagnostics
-small.webp)
Mikko PItkänen
CEO
Surgerix Oy
-small.webp)
Gurkaran Chowdhry
COO
3DBioFibR
_(3)-small.webp)
Muhammad Al-Qaisi
CEO
Aliph Medical
_-_2026-03-18T093309.787-small.webp)
Marcin Golebicki
CEO
EBAMed
-small.webp)
Darren Obrigkeit
CEO
Resivant Medical
-
-small.webp)
Crispin Simon
CEO
Prothea Technologies
Rachid Zerouali
SVP Business Development EMEA
Veranex
_(13)-small.webp)
Gokce Gun
Analyst
We Venture Capital
-small.webp)
Simon Meier
CEO
Oxford Cancer Analytics
-small.webp)
Bart Sanders
CEO & Founder
STENTiT
-small.webp)
Gilad Hizkiyahu
CEO
ProArc Medical
-small.webp)
Sandra Grau-Bartual
Founder & CEO
RespirAq
-small.webp)
Angelica Mandaric
Co-Founder & CEO
Concipio Fertility
-
Kevin Lobo
Chair and CEO
Stryker
Bernard Zovighian
CEO
Edwards
Pat Beyer
CEO
Conmed
Josep Ll Sanfeliu
Managing Partner
Asabys Partners
Murielle Thinard McLane
President & Managing Partner
Intuitive Ventures
Antoine Papiernik
Managing Partner & Chairman
Sofinnova Partners
-
Josh Makower
Professor of Medicine/Bioengineering, Director/Co-Founder, Stanford Mussallem Center for Biodesign
Venture Partner, Sofinnova Partners
Chris Eso
VP, Global Head of Corporate and Business Development, M&A and Ventures
Medtronic
Cécile Dupont
Partner
Sofinnova Partners
Hanson Gifford
Managing Partner
The Foundry, Inc.
Louise Warme
Corporate Venture Capital Director
We Venture Capital
Carey Smith
Founding Contrarian
Unorthodox Ventures
-
Ed Rubin
Leader, Gore Ventures
W.L. Gore and Associates
John White
Managing Director
KCK Medtech
Mike Carusi
Managing Partner
Lightstone Ventures
Hinke Malda
Vice President - Head of Corporate Venture Capital
Philips
Dave Adair
Managing Partner, Co-founder
Solas BioVentures
Luc Marengere
Managing Partner
TVM Capital
-
Marc Subirats
General Partner
Nina Capital
Lærke Engkilde
Vice President
Novo Holdings
Alessio Beverina
Founder & Managing Partner
Panakes Partners
Catherine Mohr
President
Intuitive Foundation
Raymond Cohen
Venture Partner
LifeScience Advisors and Wayfinder Advisors
Virginia Giddings
Vice President, Exploration
Edwards Lifesciences
-
Kevin Cheng
Partner
MVM Partners
Greg Garfield
Senior Managing Director
KCK Medtech
Fernando Pacheco
Investment Director
Endeavour Vision
Yael Nir
Senior Director of Exploration
Edwards
Henry Zubaida
Investment Manager
Gilde Healthcare Partners B.V.
Aneta Sottil
Partner
Andera Partners
-
Jan Engels
Senior Investment Manager
HTGF High-Tech Gründerfonds Management GmbH
Gokce Gun
Analyst
Werfen S.A.
Daniel Allen
Principal
Unorthodox Ventures
David Belitz
Partner
Solas BioVentures
Daniel Gilbertson
Sr. Corporate Development Director
Medtronic
Kate Jackson Hobbs
Corporate Development & Strategy Leader
Intuitive
-
Imran Hamid
Senior Director, Venture Investments
LivaNova
Thom Rasche
Managing Partner
Earlybird Health Management GmbH & Co. KG
Kenny Nova
Managing Partner
NeoPrima Ventures
Mireia Angulo
Investment Director
Namarel Ventures
Claudio Nessi
Managing Director
Omega Funds
Celia Hart
General Partner
Supernova Invest
-
Raphaël Wisniewski
Partner
Andera Partners
Nir Goldenberg
Sr. Director, Business Development
Mayo Clinic
Sylvain Sachot
Partner
Asabys Partners
Giovanni Carfi
Associate
Gyrus Capital
Maite Malet
Principal
Asabys Partners
Adam Rosenwach
Founding Managing Partner
Star51 Capital
-
Philip Kowalczyk
Chief Strategy and Corporate Development Officer
LivaNova
Ehsan Jabbarzadeh
Venture Partner
IAG Capital Partners
Srijoy Mahapatra
Divisional Vice President
Abbott
Janke Dittmer
General Partner, Head of European HealthTech Investments
Gilde Healthcare
Joe Jacobi
Co-Founder, Partner, & Chief Relationship Officer
Elevating Leadership Institute
Susana Amorim Lopes
Investment Manager
Gilde Healthcare
-
Diana Saraceni
Co-Founder and Managing Partner
Panakes Partners SGRSPA
Matthew Abdel
Chair of the Surgical and Procedural Practice
Mayo Clinic
Laurent Pacheco
Managing Partner
International Family Office Alliance for Health
Olivier Litzka
Partner
Andera Partners
Anne Osdoit
Partner, Sofinnova Partners - MD Start; CEO, Moon Surgical
Sofinnova Partners
Yannick Vancoppenolle
Partner
VIVES Partners
-
Philippe Durieux
Managing Partner
VIVES Partners
Mithi Thaya
General Partner
271.vc
Michael Wang
Managing Director, GC Venture
Medtronic
David Allen
Vice President | Corporate and Business Development
Medtronic
Stefan Fischer
Managing Partner
TVM Capital
Andrew Pieprzyk
Vice President, Strategic Development
Hologic
-
Jinny Lee
VP, Exploration and Strategic Marketing
Edwards Lifesciences
Caroline Gaynor
Partner
Lightstone Ventures
John Yianni
Partner
Earlybird
Christophe Van der Linden
Managing Director
WMC BV
Robert (Bob) Schulz
Chief Partnership Officer
Nina Capital
Anita Watkins
Managing Director
REX Health Ventures
-
Joey Mason
Venture Partner
Claret Capital Partners
Rachel Rea
Senior Director Business Development
Stryker
Roman Rothaermel
Investment Principal
SCI Ventures
Reinhard Krickl
Venture Partner
Hadean Ventures
Frank Bulens
Partner
Xpand Partners
Jake Goble
Innovation Leader, Medical Products Division
W.L. Gore and Associates
-
Barak Singer
Executive VP, Head of Healthcare
The Trendlines Group
Bibi Sattar Marques
Partner
BUENAVISTA EQUITY PARTNERS
Philipp Lechner
Principal Venture Capital
TVM Capital
Hubert Birner
Managing Partner
TVM Capital
Kyle Sherrill
Investment Manager
Nina Capital
Tyler Hayes
Investment Director
Philips
-
Kinshuk Kocher
Investment Principal
Cedars-Sinai Technology Ventures
Melissa Lezameta
Associate
Epidarex Capital
Evan Castiglia
Partner
Thuja Capital Management
Alexandre Cordier
Associate - Healthcare
Supernova
Yahel Halamish
Partner
Nina Capital
Boaz Lifschitz
Co-Founder & Managing General Partner
Peregrine Ventures
-
Johannes Fischer
Partner
Wellington Partners
Diego Serrano
Investor
Sofina
Lisa Carmel
Chair Business Development
Mayo clinic
Raf Roelands
Investment Director
HERAN Partners BV
Filip Pintelon
Investment Director
Capricorn Partners
Pieter Wijffels
Venture Partner
NLC Health Ventures
-
Sebastian Anastassiou
Partner & Head of Investments
Nina Capital
Andreas Wuepper
Director Investments Europe
Fresenius Medcial Care Ventures GmbH
Karl Stoklosa
CEO
Precisis
Lior Shahory
General Partner
Peregrine Ventures
Yvonne Bokelman
Executive Director
MedtechWOMEN
Fiorela Kapllanaj
Sr. Analyst
Nina Capital
-
Raj Shah
CEO
GuideAI Health
Marcin Golebicki
CEO and Founder
ReNavie Sensing
Jochen Reinöhl
CEO
Coramaze Technologies
Bart Bandy
Chief Executive Officer
Solenic Medical
Ana Maiques
CEO & CoFounder
Neuroelectrics
Alexis Peyroles
CEO
BetaGlue Therapeutics SpA
-
Pri Hancock
CFO
Echopoint Medical
Peter Fischer
CEO
Inkspace Imaging
Enrique Vega
CEO
Azalea Vision
George Kramer
Founder & CEO
NeoCor
Regina Atim
Founder
Clinicians Touch ALLYVE
Finbar Dolan
CEO
VERSONO Medical
-
Roger Zickfeld
Managing Director
Weild & Co.
Jason Wolfe
Business Leader - Gore Ventures (Sr Vice President)
W.L. Gore and Associates
Timothy Still
Operating Advisor
Revival Healthcare Capital & TSTILL Enterprises
Luc Starmans
Partner
Brightlands Venture Partners
Edward Ruppel
Senior Associate
Nexus Neurotech Ventures
Ken Nelson
Founder & Managing Partner
Nelson Jennings Ventures
-
Tal Wenderow
Founding Managing Partner
Star51 Capital
Marc Gliner
Managing Director
Fullstim
Chris Church
Principal
BlackRock
Kristopher Carver
Associate Director, Venture Capital
Boston Scientific
Zeeshan Syedain
CEO
Vascudyne Inc
John Santini
President & CEO
Vergent Bioscience
-
Moises Barbera Ramos
Founder and CEO
CLARO Surgical
Paul Sargeant
President & Chief Executive Officer
Circular Genomics
Marcel Both
CEO
PharmaSens AG
Jannis Fischer
CEO
Positrigo
Lucas Decuypere
CEO
Allegro
Rubén Molina
CEO & Co-Founder
INNITIUS
-
Solveig Johannessen
CEO
Dova Health Intelligence
Veronique Ameye
CEO
ElectraDx
Sean Morris
President & CEO
Amplifi Vascular
Christopher Lee
Co-Founder & CEO
HapticHeart Solutions, Inc.
Lloyd Diamond
CEO
Nitinotes
Will Mauldin
CEO
RIVANNA
-
Bertrand Moal
CEO
DESKi
Tonya Dowd
EVP Corporate Development
PRIA Healthcare
Francis White
CEO
Heart Biotech Ltd
Malin Nilsson
CEO
Inossia
Thomas Weindl
CEO & Co-Founder
OLI
Christopher Carlton
Chairman and CEO
Accure Acne
-
Hamed Hanafi
CEO
NovaResp Technologies Inc
Manios Dimitrakakis
CEO
Panda Surgical
Gunter Trojandt
Managing Director
MDA - Medical Decision Alliance GmbH
Marc Zemel
CEO
Retia Medical
Christopher Gleason
President & CEO
Moximed
Laura Becerra-Fajardo
CEO
FORESEE MedTech
-
Tushar Sharma, PhD
CEO & Founder
Vivifi Medical Inc
Nitzan Hirsh
Co-Founder and CEO
LuSeed Vascular
Koen van Breugel
Investment Director
Coronet Ventures
Fabian Ngo
Chief Strategy Officer
CathWorks
Natalie Sickler
Chief Business Officer
CathWorks
Michael Mandel
President
T45 Labs
-
Kristien Esser
CEO
GS Capital Connect
Emile Jones
EMEA Manager
Uniphar Logistics
Aline Noizet
Community Manager
Nina Capital
Evan Melrose, MD
CEO
Elevage Medical-Patient Square Capital
Agata Guilherme
Experiential Marketing Specialist - Events
Medidata
Scott Huennekens
Chairman
Front Foot Ventures
-
Nadim Yared
Chairman, CEO
Encora Therapeutics
Michael Blue
President & CEO
HistoSonics
Lee Fleisher
CEO
Rubrum Advising
Robert Kieval
President and Chief Executive Officer
Arctx Medical, Inc.
Yana Reshetnyak
CEO
CleanMargin
Menachem Genut
Co-Founder & Chief Scientific Officer
YOPI
-
Christos Bergeles
Founder and CEO
Revitalise
Jeremy Wheeler
CEO
BIOCAPTIVA LTD
Maria Artunduaga
Founder & CEO
Samay
Edouard Fonck
CEO
Cairdac
Dr. ir. Christoff Heunis
CEO
Flux Robotics B.V.
Vincent Legay
General Manager, EMEA Region
NAMSA
-
Deepak Sahu
Managing Director
Trinity Life Sciences
Joe Mullings
Chairman & CEO
The Mullings Group Companies
Mike Feher
Co-Founder, Chief Financial Officer
NovoMed
Alyssa Howard
Vice President, Business Development
MCRA
Joshua Eckelberry
Principal
Solas BioVentures
Bryant Grigsby
CEO
PDV MedTech
-
Barry Grossman
Partner
Ellenoff Grossman & Schole LLP
Sabing Lee
Partner
Knobbe Martens, Partner
Yuval Mandelbaum
CEO
Discure Technologies
David Hochman
CEO
Orchestra BioMed, Inc.
Ramin Mousavi
Founder, Chairman & CEO
NovoMed PARTNERS
Roger Brooks
Founder, CEO, C-suite Executive Search
RBrooks Group
-
Henk Westendorp
Venture Partner, Lead Surgery, Head of Clinical Expertise
NLC Health Ventures
Lars Olthof
Investment Director & Head of Venture Finance
NLC Health Ventures
Kristin Duffey
Sr. Conferences & Events Specialist
Veranex
Adam Saltman
Chief Medical Officer
NAMSA
Deepak Sahu
Managing Director
Enam Holdings
Carolina Aguilar
CEO & Co-Founder
INBRAIN Neuroelectronics
-
Steve West
Managing Director
Healthliant Ventures @ Tanner Health
Mathieu RIMAUD
CEO
Twinsight
Anna Nikitina
Business Development and Legal Advisor
Clinical Accelerator LTD
Hannah Tapsell Chapman
Investor
Mercia Ventures
Euan Thomson
Venture Partner
Precision Life Science Partners
Chaim Lotan
Chief Innovation Officer
Hadassah Hebrew University Medical Center & SmartValves
-
Colby Holtshouse
CEO
May Health
Bruce Ramshaw
CMIO
Caresyntax
Gautam Kainth
Partner
TCP Health Ventures
Elliot Street
CEO
Inovus Medical
Arthur (Yen Yu) Chen
Managing Partner (執行合夥人)
BE Health Ventures
David Caumartin
CEO
Rebrain
-
Joana Cartocci
Cofounder & COO
Robeaute
Alexander Marcantonio
Partner
Madryn Asset Management
Ivanny Franklin
Managing Partner
MedSight Capital
Elisenda Bonet Carné
CEO & Co-founder
fetaLife Technologies
Salma Al Zu'bi
Investment Principal
Hikma Pharmaceuticals
Christopher Campbell
Managing Partner
Precision Life Science Partners
-
Robert Ward
MedTech IP Attorney
Greenberg Traurig LLP
Christopher Morton
Business Executive and CEO (Founder)
ELEM Biotech
Bill Little
VP Corporate Development & Strategy
Orchestra BioMed
Roger Assaker
CEO
MDsim
Chris Bolten
MedTech IP Attorney
Greenberg Traurig, LLP
John Propst
Managing Partner
Ground Effect Ventures
-
Sanjay Kakkar
CEO
Tensive
Maurits Huigen
CEO
Gilbert
Tristan Smith
Principal
Unorthodox Ventures
Lewis Kilongo
Principal
Unorthodox Ventures
Ryan Kaeding
Managing Director
Trinity Capital
Meni Iamberger
COO
SmartValves
-
Shy Zyman
Chief Executive Officer
Cell-Lipo
Damé Medarski
COO
GS Capital Connect
Hilla Benpazi
Founder & CEO
Avertto Medical LTD
Luca Ravagnan
CEO
WISE SpA
Shola Oyewole
Vice President - Digital Innovation
United Therapeutics Corp
Scott Whitaker
President & CEO
AdvaMed
-
Jingbo Zhai
General manager
HiMed Angel Investment Co., Ltd.
Gurpreet Singh
CEO
Respiree
Barry McCann
CEO & Founder
NUA Surgical Ltd
Manoj Bhargava
Partner
Sidley Austin
Martin Deterre
CEO
Theraclion
Mathias Bouzereau
Senior Business Development Director, International
Pulnovo
-
Carlos Navarrete
Junior Business Developer
Catalonia Health
François Rosenfeld
Partner
Mérieux Equity Partners
Ariane De Marcillac
Associate - HealthTech
Gilde Healthcare Partners B.V.
Dan Azagury
Clinical Advisor
Sonder Capital
Emma Heckenberg
Analysts
Solas BioVentures
Haruka Fujita
Business Development Manager
Teijin Holdings Europe B.V.
-
El Nouchi Elisa
Senior VC Associate - Life Sciences
Bpifrance Investissement
Sonia Martinez Arca
Co-founder and CEO
Batea Oncology
Yuriy Onyskiv
Principal, Ventures
Orlando Health Ventures
Anders Lykke Iversen
Senior Associate
Novo Holdings
Eric Tansky
Managing Director
Oppenheimer
Sebastian Kronmueller
Senior Vice President, Head of Strategy and Ventures
Philips
-
Jian Luo
Business Development, Sr. Director, Greater China
BD
Mohamad Alkhouli
Vice Chair for Strategic Partnerships
Mayo Clinic
Kristoff Goson
CEO
Pixee Medical
Adam Gridley
CEO
Vergent Bioscience
Arash Dodge
CEO
Haermonics BV
Pablo Fernández
CEO
Polimerbio
-
Louis De Lillers
CEO
CorWave
Hamzeh Abdul Hadi
Senior Principal
Angelini Ventures
Sai Abhilash Lingala
Associate Director
Global Innovation Hub (Global HealthX)
Yvette Lu
Venture Partner
BE Health Ventures
Maya Misra
Senior Analyst
Angelini Ventures
M. Shane Ray
CEO and CCO
Hemanext, Inc.
-
Margot Huysmans
Analyst
HERAN Partners II BV
Aswin Hoffmann
EiR / Co-Founder
BEAMRION
Peter Stalmans
Head of Clinic - Kliniekhoofd
UZ Leuven
Robert King
Partner
1540 Ventures, LLC
Alexandra Abreu
VC
Angelini Ventures
Ping Li
Regulatory, Government Affairs & Market Access, VP, Greater China
Becton Dickinson Medical Devices (Shanghai) Co., Ltd
-
Ainhoa Manterola Solans
Managing Director
Sofina
Gonzalo Rubio Paris
Board Member
Sprim Global Investments
James Deng
Senior Vice President
Becton Dickinson (BD)
Julien Brohan
Director, Medtech Ventures
Cedars-Sinai Technology Ventures
Melissa Muller
Founder & Principal Consultant
Muller Advisory Company
Sofia Spjuth
VP Clinical Affairs, Europe
Veranex
-
Pablo Morales
Chief Medical Officer
Veranex
Cas Dercksen
Managing Partner
SALIMANDER
Alex Joseph
Chief Executive Officer
Microsure
Simon Mifsud
Chief Executive Officer
Garland Surgical
Martin French
CEO
Carelight
Joel Krupa
Chief Academic Officer
Agents of Discovery
-
Scott Xiao
Co-Founder and CEO
Luminopia
Dr. Tim Kaufmann
Founder and Chairman
LifeShield Medical
Dr. Erland Hermansen
Orthopedic Surgeon
NAMSA
Aidan Mulloy
Founder and CEO
Eclipse Medical
Rudolf Schulze Vohren
Co-Founder and CEO
Nano4Imaging
Steve Motes
CEO
Tulyp Medical
-
Maria Leiloglou
CEO
Enacuity
Miguel Luengo-Oroz
CEO & Founder
Spotlab.ai
Mathieu PIERONNE
Director
Andera Partners
Antonio Limatola
Senior Associate
Asabys Partners
Bryan Lord
CEO
Pristine Surgical
Joseph Heanue
CEO
1540 Ventures
-
Weronika Michaluk
MedTech Practice Lead
HTD
JCris Salinas
Senior VP
Medidata Solutions
Anna Hildebrand
Inaugural Principal
Star51 Capital
Eliot Horowitz
Founder & CEO
Viam
Edwin Lindsay
Managing Director
CS Lifesciences
Tom Farr
Executive Search Consultant
The Mullings Group Companies
-
David Chersky
VP of Strategic Sales
PDV MedTech
Jacob McLaughlin
CEO
New to Medical Device Sales
Indraneel Bardhan
Founder and Partner
EOS Intelligence
Pall Johannesson
Executive Vice President, Europe
Greenlight Guru
Suzie Bangle
Head of Medical Device
Barrington James
Lauren Sirek
Manager, Business Development & Marketing
PRIA Healthcare
-
Rachel Knutton
CEO
Alluvia Studio
Souvik Paul
CEO & Founder
Aurie
Yuval Shklarsh
Founder & CEO
Kudu Med
João Curado
CEO
Flomics Biotech
Nahum Ferera
Co-Founder & CEO
EyeYon Medical
Nadav Agian
CEO
Append Medical
-
Michael Behr
CEO
Prolifagen
Alexa Buck
Co-Founder
PACATIS
Menachem Genut
Co-Founder & Chief Scientific Officer
YOPI Technologies R&D LTD
Simone Pollano
Co-founder & Investor Relations Officer
CardYograft
Todd Pope
Senior Partner
Revival Healthcare Capital
Daniel Rose
CEO
Endovascular Engineering
-
Nadim Yared
Founder
Antibes Ventures
Nacho Abia
CEO
Grifols
Amir Gross
CEO Cardiovalve
SmartValves
Addie Harris
Partner
Precision Life Science Partners
Euan Thomson
Venture Partner
1955 Capital
Henry Peck
Chief Business Officer
LSI
-
Prashant Chopra
Founding CEO
Petal Surgical
Nicholas Theodore
Co founder and Board Member
Petal Surgical
Alexandre Cordier
Associate - Healthcare
Supernova Invest
Ileana Lindeman
Venture Partner, Orthopedics, Spine & Surgery
NLC Health Ventures
Leonhard Riehle, MD
Co-Founder & CMedO
Noah Labs
Olivier Taelman
CEO
Nyxoah
-
John Schindler
Co-Founder & CEO
Liquet Medical Inc.
Joan Grasas
CEO
Debios Diagnostics
Jay Kapoor
Business Development Lead
Sealantium Medical
Wolfgang Kintzel
Co-CEO & CSO
PreciPoint
Frank K. de Gioia
CEO
Collin Robotics
Sanjay Shrivastava
CEO
Innova Vascular, Inc.
-
Ohad Arazi
President and CEO
Subtle Medical
Michael Gürtler
Chief Commercial Officer
RSP Systems A/S
Tim Lawrie
CEO & Founder
Projectus Consulting
Jordi Martorell
CEO & Co-Founder
Aortyx
Eliane Schutte
CEO
Xeltis
Diego Serrano
Investor
Sofina Group
-
Marta G. Zanchi
Founder & Managing Partner
Nina Capital
Harnik Shukla
Partner
Knobbe Martens
Laura Yecies
CEO
Osteoboost Health
Magnus Jensen
CEO & Co-Founder
ClariDX
Jonas Steinhäuser-Meerz
CEO & Co-Founder
NGScopes
Morgan Mills
Senior Director
FloodGate Medical
-
Francis White
CEO
Heart Biotech Holdings
Mark Bouw
Founder & CEO
Straterra Australia
George Kramer
CEO
Neocor Medical Devices
Etienne Nichols
Head of Partnerships
Greenlight Guru
Anita Watkins
Managing Director
UNC Health Ventures
Maxwell Munford
CEO & Founder
OSSTEC
-
Juan Alcantara Morales
CEO
Nuubo
Gregor Strobbe
Founder CEO
Clouds of Care
Jessica Achtsam
Partner
Knobbe Martens
Omid Akhavan
Managing Director
Anthro Ventures
Thomas Weindl
CEO & Co-Founder
OLI Technologies
Bill Marks
Chief Clinical Officer
Paradromics
-
Andreas Wuepper
Director Investments Europe
Fresenius Medical Care Ventures GmbH
Carl Daintree
CEO
QV Bioelectronics
Rotem Kopel, PhD
CEO & Co-Founder
ABILITY Neurotech
Vili Kostamo
Medical doctor, CEO, Co-Founder
MedicubeX
Patrick Pestalozzi
CEO
Abionic
Ula Rustamova
CEO & Co-Founder
Level Zero Health
-
Christos Bergeles
CEO
Revitalise / King's College London
Maurits Huigen
CEO
Gilbert Group B.V.
Carl Daintree
CEO
QV Bioelectronics
Simone Pollano
General Manager Operations Europe
Cardyograft srl.
Nahum Ferera
CEO & Co-Founder
EyeYon Medical Ltd.
Carlos Bremer
Chief Strategy Officer
brain4care
-
Darren Sherman
Founder & COO
Orchestra BioMed
Michael Ebner
CEO & Co-Founder
Hypervision Surgical
Hunt Henrie
CBO
Tissium
Sarah Van Hellenberg Hubar-Fisher
CEO
Bioretec Ltd
Zoar Engelman
CEO
Axon Therapies
Chris Lear
Chief Strategy Officer
Prometheus Therapeutics
-
Mike Connolly
CEO
Healionics Corp.
Deniz Ozturk
VP, In Silico Technologies
Medividia
David Jacques
CEO
Sonata Medtech
Julien Penders
Co-Founder & COO
Bloomlife
Juan Abascal
CEO & Founder
ABANZA
Tony Kypreos
Entrepreneur in Residence
London Institute for Healthcare Engineering
-
Rik Kielman
CEO
Implican
Chris Hordijk
Founder/CEO
Surgical Reality
Joel Krupa
CAO
Agents of Discovery Inc.
Connor Keegan
Vice President
RBrooks Group Inc.
Robin Rump
Founder and CTO
Alpha Sophia
Yi-Kai Lo
CEO
ANEUVO
-
Nicolás Barabino
CEO
ADCORPUS MEDTECH S.L.
Andrés Vásquez Quintero
CEO/CTO & Co-Founder
Azalea Vision
Amr Salahieh
CEO
Shifamed
Mariam Maghribi
Chief Business Officer
Atia Vision
Kavi Vyas
Chief Commercial and Clinical Officer
Akura Medical
Mano Iyer
Venture Partner
Sofinnova Partners
-
Lars Kongsbak
CEO
Axithra
Michal Jaworek
CEO & Co-Founder
Approxima
Jeongwon Lee
CTO
Impact Korea Co., Ltd.
David Gascoigne
CEO
Segmed
Roger Johnston
CEO
Axial3D
Jerome Marzinski
CEO
OxSonics
-
Marcus Gerhardt
CEO & Co-Founder
Blackrock Neurotech
Dr. Margaret Kalmeta
CEO
Rapid Nexus NWS
Stéphane Corp
Co-Founder & CEO
DeepPulseNeuro
Ludwig Gutzweiler
CTO & Managing Director
Dermagnostix
Sofia Bertling
CEO
Utilizer
Maraim Maghribi
Chief Business Officer
Shifamed/Tioga Cardiovascular
-
Greg Topalian
Chairman
Opus Origin
Lily Chen
MedTech Advisor and Limited Partner
Nina Capital
Desiree Hanson
President
Opus Origin
Megan MacDonagh
Vice President
Ally Bridge
Rafael Beyar
Professor Emeritus, Medicine and Biomedical Engineering, Technion
Alive and ICI
Raj Airey
Founding partner
Convergence Partners
-
Ineke Cazander
Principal
Invest-NL
Drew Burdon
Partner
EQT Partners
Eduard Hotsul
Principal - Strategy & BD - Eurasia
Medtronic International Trading Sarl
Ian Purdy
Senior Vice President, Regulatory Affairs & Quality Assurance
Purdy Healthtech Intnl
Thomas Serena
CEO and Medical Director
SerenaGroup, INC
Eric Schantz
Principal Business Development Associate
Medtronic
-
Christian Rybak
Partner/Shareholder
Greenberg Traurig
Redd Warburton
Co Founder
Scientia Talent
Ahmed Elmouelhi
President and CEO
TRiCares
Stefan Pilz
CEO
HighLife SAS
Stacey Pugh
CEO
Endogenex
Kregg Koch
US Patent Attorney
Knobbe Martens
-
Glenn Stiegman
Senior Vice President, Clinical & Regulatory Affairs
MCRA
Michael Anselmo
VP of Reimbursement, Health Economics and Market Access
MCRA
Abigail Allen
Vice President, Clinical Affairs
MCRA an IQVIA business
Kei Müller
CEO
Ebenbuild
Weronika Michaluk
MedTech Practice Lead
HTD Health
Boris Pasche
Co-founder and Member
TheraBionic
-
Toon Overbeeke
Co-Founder & CEO
Vitestro
Claudia Rodiera, MD, PhD, EMBA
Co-Founder & Chief Medical Officer
Cufftech
Shirish Joshi
CEO & Founder
Joshi Innovations
Stefania Riboldi
Chief Technology Officer
Dialybrid
Shamus Husheer
CEO
Heartfelt Technologies
Theo Ruers
Co-founder and CEO
Juvant Medical
-
Tom Moore
President & CEO
Minze Health
Mathias Bouzereau
Senior Business Development Director, International
Pulnovo Medical
Simon Mifsud
CEO & Co-Founder
Garland Surgical Ltd
Harlee Sorkin
CEO
InterShunt
Carol Stafford
Client Executive - Medical Device & Diagnostics EMEA
Medidata
Pawel Buszman
CEO
I4HV
-
Jonas Funk
Manager Director
L.E.K. Consulting
Houman Homayoun
Co-Founder & CEO
HealtheTile Technologies, Inc.
Adrian Whitford
President
Invenio Imaging
Sascha Berger
Senior Advisor
Aescuvest Capital Partners
Omar Khateeb
CEO
MarketCraft
Ryan Wade
Principal
Wayfinder Advisors and LifeScience Advisors
-
Konrad Dobschuetz
Chief Strategy Officer
McGinley Orthopedics
Elena Lovo
Head of EMEA Life Sciences, Innovation Economy
JP Morgan
Chen Levin
Co-Founder and CEO
Earendel Medical
Brian Liles
Executive Vice President
CSSI - Cost Segregation Services
Brendan Marrinan
Head of Business Development
Innovative Catheter Solutions
Philip Taillieu
Co-founder - CEO
Cascador/moveUP
-
Chris Raphaely
Co-Chair, Health Care & Life Sciences Practice
Cozen O'Connor
Duncan Keeble
Founder & Managing Director
OxDevice Medical
Nils De Koff
Managing Director
LIMIS
Tanja Danner
CEO & Founder
Prenaital
Scott Verner
CEO
Neuroview Technology
Rob Taft
CEO
ReLAAx Medical
-
Loulia Kassem
Co-Founder & CEO
Rea Diagnostics
Mikko PItkänen
CEO
Surgerix Oy
Gurkaran Chowdhry
COO
3DBioFibR
Muhammad Al-Qaisi
CEO
Aliph Medical
Marcin Golebicki
CEO
EBAMed
Darren Obrigkeit
CEO
Resivant Medical
-
Crispin Simon
CEO
Prothea Technologies
Rachid Zerouali
SVP Business Development EMEA
Veranex
Gokce Gun
Analyst
We Venture Capital
Simon Meier
CEO
Oxford Cancer Analytics
Bart Sanders
CEO & Founder
STENTiT
Gilad Hizkiyahu
CEO
ProArc Medical
-
Sandra Grau-Bartual
Founder & CEO
RespirAq
Angelica Mandaric
Co-Founder & CEO
Concipio Fertility
Presenting
at LSI Europe ‘26
the next generation of breakthrough medtech and
healthtech companies.
-
3DBioFibR Inc. produces high performance biofibers that enable product developers to unlock new solutions.
Gurkaran Chowdhry
COO
-
ABANZA specializes in the Sports Medicine and Soft Tissue Repair market and has developed a patented platform of medical devices for soft tissue fixation, with technology designed to perform independently of bone quality and delivering market-leading biomechanical performance. The company currently has three commercial products in the U.S. and Europe, is approved across leading healthcare systems and institutions, and is expanding its platform into more than 50 surgical applications across the knee, shoulder, elbow, hand and wrist, hip, and foot and ankle.
Juan Abascal
CEO & Founder
-
ABILITY Neurotech develops a minimally invasive brain-computer interface system based on subdural ECoG electrode arrays that rest on the cortical surface rather than penetrating brain tissue. The batteryless implant transmits neural data through the skin via an optical link to an external wearable, where AI decoders translate speech- and movement-related activity into communication and device control. The company is clinical-stage, with chronic implantation studies in ALS patients underway.
Rotem Kopel, PhD
CEO & Co-Founder
-
Abionic is a Swiss diagnostics company developing rapid point-of-care technologies designed to accelerate the detection of life-threatening conditions such as sepsis. The company's PSP assay has received 510(k) clearance from the FDA. At the core of the platform is abioSCOPE®, an award-winning desktop diagnostic system leveraging proprietary nanofluidic technology to deliver quantitative results within minutes from just 50 µL of blood. The platform is designed for use in emergency and acute care settings, enabling faster clinical decision-making and earlier intervention for critically ill patients.
Patrick Pestalozzi
CEO
-
Accure Medical is revolutionizing dermatology with the Accure Laser System, the first 1726nm platform to achieve both CE Mark certification and FDA clearance for the long-term treatment of mild to severe inflammatory acne vulgaris. Leveraging its patented treat-to-temperature technology, the system ensures consistent, safe, and effective results for all skin types. With rapid adoption across the US, Europe, Asia, and the Middle East, Accure is addressing a significant global need with its groundbreaking solution for acne treatment.
Christopher Carlton
Chairman and CEO
-
Agents of Discovery empowers health and life sciences organizations, cities, universities, airports, sports teams, and other innovation hubs to create place-based learning experiences guided by interactive, AI-powered avatars. Using the Agents platform, teams can support education, workforce training, and community engagement while transforming indoor and outdoor spaces into dynamic, interactive adventures.
Joel Krupa
Chief Academic Officer
-
Aliph Medical, Inc. is developing a novel AI-driven ocular diagnostics and imaging platform that captures comprehensive structural and functional eye data from a single integrated source. The all-in-one platform, AiOne, enables more comprehensive and precise analyses across ophthalmology, optometry, and the emerging oculomics use cases.
Muhammad Al-Qaisi
CEO
-
Our lead product is Hydrocelin, a first-in-class, minimally invasive injectable therapy, designed as a disease-modifying treatment for osteoarthritis. Hydrocelin is designed to address the primary cause of osteoarthritis: the loss of the rheopectic and viscoelastic characteristics of the synovial fluid. Once injected, Hydrocelin mixes with the synovial fluid, where it adapts under load to absorb and dissipate impact forces and replicate the mechanics of healthy joint fluid through resilient nanostructured crosslinking. This restores joint function and relieves pain, while initiating a mechanobiological cascade that protects and potentially regenerates cartilage. Hydrocelin does not suppress symptoms. It corrects the physics of the joint and changes the trajectory of the disease.
Lucas Decuypere
CEO
-
-(1)-small.webp)
Amplifi Vascular is developing the Amplifi™ Vein Dilation System, a proprietary blood pump technology designed to enlarge veins and improve outcomes for patients requiring arteriovenous fistula (AVF) surgery. The system is intended to increase AVF eligibility, accelerate maturation, reduce failure rates, and extend primary patency. By addressing key challenges in dialysis access, Amplifi aims to improve treatment outcomes for patients with end-stage renal disease.
Sean Morris
President & CEO
-
ANEUVO's, ExaStim®, is a portable, wireless, multi-channel, non-invasive spinal stimulation system that delivers clinician-adjusted, patient-specific, non-invasive neuromodulation in both clinical and home settings. In Europe, ExaStim is CE marked for upper-extremity motor function in adults with spinal cord injury across injury stages and subtypes; in the U.S., it is FDA 510(k) cleared to improve hand sensation and strength in adults with chronic incomplete SCI when used in conjunction with functional task practice.
Yi-Kai Lo
CEO
-
Append Medical is a clinical-stage medical technology company developing a next-generation Left Atrial Elimination (LAE) system for stroke prevention in atrial fibrillation patients. Leveraging a proprietary vacuum-based approach that eliminates the need for a permanent implant, Append aims to address the limitations of current LAA occlusion therapies by reducing the risks of device-related thrombus (DRT) and peri-device leak (PDL), while providing a transcatheter solution compatible with a broad range of patient anatomies.
Nadav Agian
CEO
-
The Approxima System is a percutaneous right ventricular reshaping technology for the treatment of tricuspid regurgitation (TR) that targets the underlying cause of the disease, right ventricular dilation. Through a straightforward implantation procedure, it reshapes the ventricle and immediately restores tricuspid valve function, it aims to prevent disease progression, and preserves the native valve, enabling versatile long-term patient management. First-in-human study is underway.
Michal Jaworek
CEO & Co-Founder
-
Arctx Medical, a clinical-stage medical technology company, is developing the world's first targeted treatment for Acute Pancreatitis (AP), and is introducing a superior new approach for patient temperature management. Targeted cooling is a well-established therapy for treating acute inflammatory conditions within the body. The Arctx Cool Catheter™ (ACC) Set delivers minimally invasive, selective, and potent cooling therapy to the pancreas, intended to reduce inflammation, accelerate patient recovery, and prevent more serious complications including organ failure and death. Arctx is embarking on an IDE-approved US pivotal clinical trial for this first-ever dedicated treatment for AP. In addition, Arctx now has FDA clearance for the ACC for patient temperature management, a second and mature market for its technology in which it is beginning to commercialize.
Robert Kieval
President and Chief Executive Officer
-
Aurie holds FDA Class II De Novo clearance for the world's first safely reusable catheter system: one patented reusable catheter and an easy-to-use portable washer-disinfector with pre-packaged supplies replaces 100 single-use catheters at standard-of-care pricing, halving life-threatening infection risk and cutting catheterization waste by more than 67%. Incumbents have left the $3B intermittent catheter market stagnant for three decades with limited innovation. Two large RCTs (MultICath, COMPaRE) have now validated reuse and consumer demand for reusable alternatives to single-use catheters; Aurie is the only cleared system built to capture the shift.
Souvik Paul
CEO & Founder
-
Avertto Medical is developing a non-invasive monitoring platform that continuously measures bilateral carotid artery pressure waveforms in hospitalized patients. The technology combines proprietary sensors and signal-processing algorithms to track physiological changes in carotid hemodynamics and provide real-time monitoring of cerebrovascular status in clinical settings.
Hilla Benpazi
Founder & CEO
-
Patient-specific care has historically relied on manual, bespoke workflows that are difficult to standardize and scale. As demand grows, medical device companies need a digital infrastructure capable of processing imaging, planning, and device workflows consistently at volume. Axial3D provides an AI-powered, cloud-based, configurable platform that automates these processes, enabling medical device companies to standardize and scale patient-specific programs across products, teams, and markets. Its FDA-cleared technology and regulatory infrastructure provide a foundation for scaling patient-specific solutions across medical device portfolios and making patient-specific care routine.
Roger Johnston
CEO
-
Axithra is developing a photonics-based diagnostic platform for measuring both unbound and total drug concentrations directly from blood in approximately 15 minutes. The platform uses Raman spectroscopy to support therapeutic drug monitoring and individualised dosing in hospitals, with future applications in outpatient care.
Lars Kongsbak
CEO
-
Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.
Andrés Vásquez Quintero
CEO/CTO & Co-Founder
-
Batea Oncology develops innovative therapies for glioblastoma , with the aim of improving treatment outcome and patient survival rates.
Sonia Martinez Arca
Co-founder and CEO
-
BEAMRION is developing the world's first real-time magnetic resonance imaging (MRI)-guided proton therapy platform, combining ionizing radiation-free, high soft- tissue contrast live anatomical imaging, AI for fast online and real-time adaptive treatment workflows, and beam-agnostic therapy guidance in a fully integrated clinical system. BEAMRION is building an innovative live in-beam MRI-based "GPS" solution that unlocks real-time adaptive high-precision radiation therapy for moving tumors and expands the range of radiation treatment indications even beyond oncology. BEAMRION's in-beam MRI solution is designed to be deployable and scalable as a retrofit in existing treatment rooms or fully integrated MR-guided proton therapy system into new rooms.
Aswin Hoffmann
EiR / Co-Founder
-
BetaGlue Therapeutics is pioneering targeted nuclear therapies for solid tumours. YntraDose, our solution, is a combination of a biocompatible bioglue and Yttrium 90 microspheres, that is designed to transform pancreatic cancer treatment through localized, effective, and safe therapy.
Alexis Peyroles
CEO
-
BIOCAPTIVA develops
Jeremy Wheeler
CEO
-
Blackrock Neurotech designs, manufactures, and supports the world's most validated implantable brain-computer interface (BCI) systems. Our high-fidelity neural recording and stimulation technologies power advanced neuroscience research and restore independence for people with paralysis and other neurological disorders. Since 2004, our long-tested human BCI platform -- anchored by the FDA-cleared 96-channel Utah Array (K110010) -- has demonstrated an unmatched safety profile with over 55,000 days of human implant data, including the longest continuously implanted BCI in a human at over 11 years, and has enabled more than 56 patients to regain movement and communication over sustained, multi-year use.
Marcus Gerhardt
CEO & Co-Founder
-
Bloomlife has developed a tech-enabled remote prenatal monitoring platform combining its unique medical wearable for maternal-fetal monitoring, connected devices, AI-based predictive analytics and clinical services. Bloomlife shifts maternal and prenatal care from costly hospital environments to home, improving birth outcomes for moms and babies. Bloomlife contracts with clinics and leverages existing reimbursement codes to create financially accretive programs for its partners.
Julien Penders
Co-Founder & COO
-
A category-defining neurotech that makes intracranial dynamics visible early, turning previously invisible physiology into actionable insight to prevent brain damage. Backed by 146 publications, 49 patents, and a network of global KOLs, brain4care is redefining the magnitude and timing of intervention by enabling a real-time, bedside, and non-invasive way to assess the risk and trend of neurological deterioration over time.
Carlos Bremer
Chief Strategy Officer
-
Cairdac is a French medtech company developing a new generation of leadless pacemakers powered by the heart itself, designed to eliminate the fundamental limitations of current cardiac pacing systems and redefine the standard of care. ALPS™ enables a fully self-powered, leadless pacemaker combining continuous monitoring, expanded pacing capabilities, and long-term autonomy. This approach allows Cairdac to overcome the key trade-offs that have so far limited the adoption of leadless technologies. The company is preparing its clinical studies
Edouard Fonck
CEO
-
CardYograft develops Cardiac Micrograft Therapy (CMT), an autologous cardiac patch prepared at the point of care: during cardiac surgery, tissue from the patient's own right atrial appendage is mechanically processed in the operating room with a CE-marked disaggregation device and applied over the left-ventricular scar, in parallel with the ongoing procedure. Because the graft is autologous and prepared intraoperatively, the therapy involves no cell expansion, no cold chain and no immunosuppression, and is being developed as a Class III device under EU MDR rather than as an ATMP. Its target population is heart failure with reduced ejection fraction and post-infarction scar, initially in patients undergoing coronary artery bypass grafting, with a mini-thoracotomy access under development to extend the therapy beyond bypass candidates.
Simone Pollano
Co-founder & Investor Relations Officer
-
Carelight enables wearable, medical-grade monitoring and assessment of health biomarkers throughout the full patient journey, from home monitoring to ICU. Our goal: better health outcomes through continuous medical grade data, earlier disease detection, and improved decision-making. Our OPM technology, incorporating multi-wavelength, 3D optical sensing with AI-adaptive illumination, yields high-quality pulsatile waveforms for robust personalised cardio-respiratory insights beyond current wearables. Carelight's first product, a wrist worn pulse oximeter, overcomes skin tone related errors in non-invasive blood oxygen measurement, addressing long standing questions of iniquity in pulse oximetry devices.
Martin French
CEO
-
Circular Genomics is a biotechnology company revolutionizing neurological and psychiatric precision medicine. The company provides a unique understanding of dynamic brain processes that will transform how neurological and psychiatric conditions are diagnosed and managed leveraging unique, brain-enriched circular RNA biomarkers via simple blood tests. These biomarkers serve as ideal neurological biomarkers. We are advancing tests in Alzheimer’s and Parkinson’s Disease.
Paul Sargeant
President & Chief Executive Officer
-
Harmless and dangerous oral lesions often look alike, prompting precautionary biopsies. However, more than 97% of oral biopsies are negative for cancer. ClariDX is developing OralClarity, a handheld Raman spectroscopy probe with a single-use tip that analyses tissue biochemistry and provides immediate lesion-risk feedback. It removes healthy patients from the treatment pathway and accelerates care for those who need it. We enter the market through specialist oral medicine and maxillofacial surgery, scale into general dentistry, and extend the platform into gastrointestinal endoscopy.
Magnus Jensen
CEO & Co-Founder
-
Claro Surgical is reinventing orthopedic surgeries with the latest in mixed reality and artificial intelligence via the only FDA-registered platform: OrthoMR.
Moises Barbera Ramos
Founder and CEO
-
CleanMargin is a clinical-stage company developing the proprietary fluorescent surgical imaging agent, MarginVue, that enables surgeons to precisely visualize and remove all cancer lesions during breast-conserving cancer surgeries to achieve clean (cancer-free) surgical margins, addressing a large unmet medical need in breast cancer and many other cancer surgeries. Our ongoing Phase II clinical trials conducted at Memorial Sloan Kettering Cancer Center together with our device partner, Stryker Corp., demonstrate that MarginVue is safe and detects all sub-types of breast cancer with 100% sensitivity
Yana Reshetnyak
CEO
-
Clinicians Touch ALLYVE is developing a wearable maternal bracelet and corresponding application that collects patient-generated data during pregnancy. The device will empower tracking of key data that can be shared with providers to improve outcomes during pregnancy.
Regina Atim
Founder
-
Clouds of Care is a technology-enabled clinical development partner focused on advancing precision medicine for people with Central Nervous System disorders. The company specializes in applying neurophysiology, digital health technologies, and its data-driven AI-powered biomarker platform to improve the detection and interpretation of treatment effects in clinical trials.
Gregor Strobbe
Founder CEO
-
Collin Robotics is a pure-play ENT robotics and navigation company that develops RobOtol, an ENT microsurgical robot with 5-micron spatial accuracy and an installation base of 27 sites across 12 countries, and a real-time electromagnetic CNS navigation system for ENT and cranial procedures, with an installation base of 326 sites across 26 countries. The company is developing a second-generation platform to extend capability to support all high-precision cranial microsurgery procedures.
Frank K. de Gioia
CEO
-
Concipio is developing an AI-enabled OS for fertility clinics that combines end-to-end workflow with precision technology, embedding AI decision aids that can optimise clinical outcomes and predictability from diagnostics to treatment and medication management. Pilot live at Oxford Reproductive Health, with regulated modules in development on an MDR and FDA path.
Angelica Mandaric
Co-Founder & CEO
-
CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology.
Louis De Lillers
CEO
-
Quantitative neuromuscular monitoring is essential during anesthesia and recovery to improve patient safety and help reduce postoperative respiratory complications and associated healthcare costs. Cufftech integrates quantitative neuromuscular monitoring directly into the blood pressure cuff, offering a disruptive form factor designed to make objective monitoring simple, seamless and accessible in routine clinical practice, with the goal of improving patient safety and outcomes while reducing the clinical and economic burden associated with postoperative complications. Founder-funded to date, Cufftech is currently pre-revenue and in the final stages of CE marking certification (expected Q2 2027), and is now launching its first external investment round to support commercialization and international expansion.
Claudia Rodiera, MD, PhD, EMBA
Co-Founder & Chief Medical Officer
-
Debios Diagnostics is an IVD spin-off of IGTP, a Barcelona-based hospital research institute. Its lead product, FIBROKIT®, is a urine-based IVD for the non-invasive assessment of renal fibrosis, a key prognostic factor in chronic kidney disease (CKD), with CE marking targeted for Q4 2027. Supported by biopsy-referenced evidence in native-kidney and transplant patients, it improves fibrosis detection by 25% when used alongside albuminuria, with applications in patient stratification and monitoring across kidney transplantation, clinical nephrology and pharmaceutical R&D.
Joan Grasas
CEO
-
DeepPulseNeuro is developing an endovascular neural interface to record intracranial electrical activity from the brain through the cerebral venous system. Starting with drug-resistant epilepsy, the technology is designed to enable less invasive access to deep-brain electrophysiology and broaden the clinical applications and patient populations that can benefit from intracranial neural monitoring.
Stéphane Corp
Co-Founder & CEO
-
-small.webp)
Dermagnostix manufactures and markets a fully automated, cartridge-based molecular diagnostics platform integrating sample preparation, nucleic acid amplification, and fluorescence detection on centrifugal microfluidic disks. Current applications focus on gene-expression diagnostics in dermatology, while the platform can also support molecular assays in other clinical and research fields.
Ludwig Gutzweiler
CTO & Managing Director
-
HeartFocus is an FDA-cleared, AI-powered cardiac ultrasound platform designed to radically expand access to echocardiography. The software provides real-time acquisition guidance and automatic quality validation, enabling clinicians with minimal ultrasound training to consistently capture diagnostic-quality transthoracic echocardiographic views. By shifting image acquisition from scarce specialists to a broader clinical workforce — including nurses, PAs, and frontline providers - HeartFocus addresses a critical bottleneck in cardiac care across emergency medicine, primary care, and resource-limited environments.HeartFocus is FDA cleared and commercially available in the United States, with early customers live and active across multiple care settings - positioning the platform for rapid scale in preventive, acute, cardiac care, and educational institutions.
Bertrand Moal
CEO
-
Dialybrid develops hybrid vascular grafts based on proprietary Silkothane®, a novel composite material joining the biocompatibility of silk fibroin and the elasticity of polyurethane. The first product in the pipeline is SAG (Silkothane® Arteriovenous Graft), a semi-degradable arteriovenous graft for use as hemodialysis vascular access, offering the short-term usability of synthetic grafts and the long-term performances of native fistulae. The product is currently being tested in a first-in-human study.
Stefania Riboldi
Chief Technology Officer
-
Horz_RGB_(1)-small.webp)
Dova is a precision health technology company that is building the AI infrastructure for how gastrointestinal (GI) health is measured, monitored, and managed. We develop AI-powered, image-based solutions that empower clinicians and researchers with actionable insights to advance GI care, as well as provide standardized, quantitative disease intelligence across clinical research and future clinical care. Our multimodal intelligence platform includes DovaVision UC, designed to support granular assessment of ulcerative colitis at scale, and DovaSound, designed to support rapid, standardized intestinal ultrasound image capture and assessment.
Solveig Johannessen
CEO
-
Earendel Medical has developed the first hands-free, multi-angle imaging platform for minimally invasive surgery. The system is designed to provide TRUE-3D visualization, two-handed operation, AI-powered views, and a single-use design. Validated hands-on by leading KOLs, with FDA clearance expected Q2 2027, the company is launching first into sports medicine shoulder and knee arthroscopy. Earendel is raising a $5M Series A.
Chen Levin
Co-Founder and CEO
-
-small.webp)
EBAMed is developing CardioKit™, a first-of-its-kind NON-INVASIVE CARDIAC ABLATION AND REAL-TIME MOTION MANAGEMENT PLATFORM designed to transform the treatment of moving cardiac targets. The company’s initial focus is ventricular tachycardia (VT), a life-threatening condition with significant unmet clinical need. CardioKit combines radiation-free, real-time ultrasound heart-motion monitoring, ECG and ultrasound-based cardiac and respiratory gating, and AI-enabled motion prediction to precisely synchronize external-beam treatment with the beating and breathing heart—without a catheter or incision. Compatible with both photon and proton therapy systems, CardioKit is designed as a scalable platform for additional ventricular arrhythmias, broader cardiac ablation applications, and other non-invasive procedures requiring precise motion management. EBAMed plans to treat its first patient in Q4 2026, providing a major near-term clinical and strategic value inflection point.
Marcin Golebicki
CEO
-
-(3)-small.webp)
Echopoint Medical is developing the IKOR™ coronary physiology system, an advanced optical sensor technology that measures coronary microvascular function in real time during routine cath lab procedures. By enabling accurate diagnosis of coronary flow, pressure & temperature, syndromes like ischaemia with non-obstructive coronary arteries (INOCA)—a condition that disproportionately affects women—IKOR helps physicians personalize treatment and reduce unnecessary stents and repeat procedures.
Pri Hancock
CFO
-
Eclipse Medical developed Omega, a left atrial appendage closure device for stroke prevention in nonvalvular atrial fibrillation. More than 1,000 devices have been implanted across Europe, and the company is preparing a US IDE pivotal trial, with IDE submission targeted for Q1 2027.
Aidan Mulloy
Founder and CEO
-
ElectraDx has developed the first lab-accurate, ultra-low-cost community ad home based diagnostic platform using proprietary intelligent electronic strip technology. Our device delivers results from a simple fingerstick in under10 minutes, connects securely to healthcare systems, and supports a broad test menu covering over 70% of common lab tests. With an initial focus on cardiac markers, we are shifting diagnostics from hospitals into every home to enable earlier intervention and better health outcomes.
Veronique Ameye
CEO
-
-small.webp)
Enacuity is an Imperial–UCL spin-out, that delivers the world's first software-only functional imaging upgrade to existing surgical cameras, improving patient outcomes.
Maria Leiloglou
CEO
-
Mr. Nahum Ferera is an entrepreneur and medical device executive with extensive experience leading innovative technologies from concept through development, regulatory approval, and successful commercialization. Nahum is the co-founder and CEO of EyeYon Medical, where he has led the development and global commercialization of EndoArt - the world's first and only synthetic endothelial implant. EndoArt represents a breakthrough approach to the treatment of chronic corneal edema, offering a non-cellular alternative to donor tissue transplantation and addressing a major unmet need in corneal care worldwide. Under Nahum's leadership, EyeYon has advanced EndoArt from an early-stage concept into a clinically validated and commercially available technology, with growing adoption by leading corneal surgeons and ophthalmic centers across Europe and Asia. The technology has also received FDA Breakthrough Device designation and approval to initiate a pivotal clinical study in the United States. Before founding EyeYon Medical, Nahum was involved in the development of medical devices in the fields of cardiac rhythm management and non-invasive glucose monitoring. In addition to his role at EyeYon, Nahum leads the Israeli Ophthalmology CEOs Group, which includes more than 60 members. He also serves as a mentor in the Israeli Bio-Executive Forum and the International MBA Program at Tel Aviv University, and as a panelist in the International MBA Program at the Technion - Israel Institute of Technology. Nahum holds an MBA and a
Nahum Ferera
Co-Founder & CEO
-
Field Medical is developing a next-generation pulsed field ablation (PFA) solution for the treatment of cardiac arrhythmia. The company is building a purpose-built system that incorporates PFA, contact force sensing, electromagnetic localization, and artificial intelligence-enabled mapping capabilities to address the limitations of first-generation PFA technologies and deliver more efficacious therapy.
-
Flomics is a biotech company developing a revolutionary liquid biopsy test that combines AI with RNA biomarkers for the early detection and management of cancer and other complex diseases. From an individual RNA profile we detect molecular signs associated with the disease and its metabolic state, making sure everybody gets the right treatment at the right time. Everything from a standard blood draw.
João Curado
CEO
-
Flux Robotics develops a magnetic navigation platform for vascular interventions. The system uses external magnetic fields to steer guidewires and microcatheters through complex vascular anatomy, supporting more controlled and predictable navigation during procedures such as blocked artery crossing and complex stent placement.
Dr. ir. Christoff Heunis
CEO
-
-(4)-small.webp)
FORESEE MedTech is a deep-tech spin-off awardee of the European Innovation Council (EIC) Transition grant (2.5 M€), that is developing an intravascular multiparametric sensing platform for remote monitoring of chronic conditions, starting with heart failure. FORESEE’s solution aims to support earlier interventions, reduce hospitalizations, empower patients and improve long-term outcomes in this cardiovascular condition. Thanks to the ability to measure multiple parameters from a single intravascular device, FORESEE will improve patient management by addressing the fact that in heart failure "one size does not fit all
Laura Becerra-Fajardo
CEO
-
Garland Surgical is developing the patented TriActiv Hip: a next‑generation, triaxial hip replacement system designed to meet the needs of today's modern and diverse patient population. Engineered to deliver a wider and more natural range of motion, the implant also provides exceptional stability and ultra‑low wear compared to conventional ball‑and‑socket designs, supporting both active lifestyles and long‑term durability. Developed in close collaboration with leading orthopaedic clinicians, academic partners, and industry experts, and evolved from the MaltaHip project, TriActiv Hip aims to offer a practical, long‑lasting solution for high‑demand and high‑risk patients, including those prone to dislocation and instability.
Simon Mifsud
Chief Executive Officer
-
Gilbert has built an enabling drug-delivery platform for the development of next-generation inhaled drug-device combinations, with pharma and CDMO partners as the commercial pathway. Gilbert's breakthrough scalable delivery platform offers the precision and adaptability modern inhaled therapies require - and the simplicity patients demand.
Maurits Huigen
CEO
-
GuideAI Health automates the early detection of chronic vascular disease in CT scans through advanced AI models developed by clinicians and AI/ML experts. The platform's first product addresses the 90% underdiagnosis/misdiagnosis rate of peripheral vascular disease in current practice by rapidly identifying and reporting subtle disease markers, enabling early intervention before life altering complications develop through disease-to-treatment precision.
Raj Shah
CEO
-
Haermonics' core technology enables Continuous Postoperative Pericardial Flushing (CPPF) to help reduce clot formation, maintain tube patency, and support drainage management during early recovery after cardiac surgery. The automated system is designed for use immediately after surgical closure and aims to reduce postoperative complications. Clinical studies have shown a 40% reduction in reintervention.
Arash Dodge
CEO
-
HapticHeart Solutions is advancing a wearable haptic feedback platform—featuring a glove and armband—that restores tactile sensation in catheter-based, minimally invasive, and robotic procedures. By converting physical and physiological signals into real-time touch and force feedback, the system aims to enhance surgical precision, shorten learning curves, and improve patient outcomes. Currently at Technology Readiness Level 6, the prototype has demonstrated clinical utility in electrophysiology and is being expanded for use in robotic surgery.
Christopher Lee
Co-Founder & CEO
-
Healionics is developing safer, more reliable means of bloodstream access to support life-saving dialysis therapy in kidney failure patients. Its FDA Breakthrough-designated STARgraft AV graft has 24-month clinical results that show outstanding resistance to both occlusion and infection — the two primary causes of failure in on-market grafts. The company also has a diverse product pipeline leveraging its core STAR biomaterial technology which can inhibit scar tissue encapsulation and infection to improve the performance of a wide range of other implantable devices and facilitate creation of entirely novel ones.
Mike Connolly
CEO
-
HealtheTile is developing a comprehensive physiological monitoring and intelligence platform that continuously measures vital signs including cuffless blood pressure, SpO₂, respiratory rate, heart rate, activity, electrodermal activity (GSR/EDA) and temperature. The platform combines multimodal wearable sensing with a physiological foundation model to enable longitudinal monitoring and early detection of heart failure deterioration after hospital discharge.
Houman Homayoun
Co-Founder & CEO
-
The Yacoub Heart Valve: A unique, tissue-engineered valve that promises to revolutionise heart valve replacement with no compromises. Using intricate scaffold technology that transforms in-situ into a living heart valve, using the body's own healing processes to regenerate as nature intended. Restoring full life expectancy and in kids, adapting and growing.
Francis White
CEO
-
The Heartfelt device is an autonomous, in-home monitoring device shown in a 180-patient randomized, blinded, sham-controlled study to reduce heart failure hospitalisations by over 50%, potentially saving Medicare alone over $20Bn/yr. It achieves this by using 3D imaging to measure patients' feet and lower legs as they pass the sensor during normal daily life. No patient interaction is required, largely eliminating the adherence problems associated with conventional monitoring. Foot swelling occurs in around two-thirds of heart failure patients 10–15 days before hospitalisation, providing enough warning for a nurse alert and timely intervention (e.g. increasing diuretic therapy) to prevent hospital admission.
Shamus Husheer
CEO
-
Hemanext is a medical technology company pioneering oxygen-controlled blood processing for red blood cells, the first innovation designed to preserve red blood cell quality throughout storage. Its Hemanext ONE® platform reduces oxidative damage during storage to preserve red blood cell quality and oxygen-delivery function, helping provide higher-quality red blood cells for patients requiring transfusion. The FDA-cleared, CE-marked technology is now in commercial stage in the United States and Europe.
M. Shane Ray
CEO and CCO
-
Impact Korea has developed a continuous pressure management platform that automates the conventional manual pressure bag used for arterial lines. The system maintains controlled pressure and monitors abnormal conditions to support arterial catheter patency and help prevent blood backflow. The technology is relevant to critical care, arterial monitoring, interventional cardiology, interventional radiology, neurointervention, and vascular access.
Jeongwon Lee
CTO
-
Implican has developed a compression ring system to create colorectal anastomosis, creating a bacteria free wound healing environment by using only submucosa. This prevents anastomotic leakage and avoids diverting stomas. This has already been proven successful in preclinical trials and in humans in the First In Human trial.
Rik Kielman
CEO
-
InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics.
Peter Fischer
CEO
-
Innitius has developed a quantitative diagnostic platform that measures cervical tissue biomechanics combined with AI models to support clinical decision-making in obstetrics. The technology addresses key use cases including threatened preterm labor, early preterm birth risk stratification, and induction of labor, enabling more accurate and objective assessment at the point of care.
Rubén Molina
CEO & Co-Founder
-
Inossia is developing a platform technology focused on reducing repeat fractures in patients receiving bone cement for fracture repair. The company's lead product, V-Flex, is a bone cement for vertebral augmentation that hardens at a significantly lower temperature compared to competing bone cements. The soft cement is ideal for osteoporotic bones to adjacent fracture risk without compromising on mechanical support.
Malin Nilsson
CEO
-
InterShunt is developing a minimally invasive catheter therapy for heart failure, the leading cause of hospitalization and Medicare expense. Currently in clinical phase, the procedure dynamically offloads left atrial pressure, addressing the most debilitating symptoms in patients with limited treatment options.
Harlee Sorkin
CEO
-
-small.webp)
Invenio's NIO system images fresh, unprocessed biopsy tissue in the procedure room in under three minutes, with no staining or sectioning. Our AI tells the physician immediately whether cancer is present, without the need for a cytotechnologist, accelerating time to diagnosis and treatment. We started with neurosurgery and now have breakthrough device designation for lung cancer.
Adrian Whitford
President
-
Technologies to restore depth perception in minimal invasive surgery and endoscopy. Our technology allows use of standard monocular endoscopes to do real time 3D visualisation. This is achieved by combining physical AI with advanced sensorics. We control camera sensor and light source and lenses in real-time to extract high-quality data that can be used for accurate depth estimation. First use case targeted is Laparoscopy. The technology can also be applied for very thin flexible endoscopes used in robotic endoluminal procedures such as bronchoscopy to visualize in 3D.
Shirish Joshi
CEO & Founder
-
Juvant Medical has developed a technology platform for real time tissue diagnosis based on state of the art optical technology, based on light – tissue interaction and AI aided analysis. The technology is applicable throughout the full oncology care cycle, from diagnosis to treatment monitoring, informing the clinicians in real time on tissue diagnosis during biopsy or cancer surgery. SmartScan will be the first product Juvant will bring to market, directed to real time tumor margin assessment and surgical guidance during surgery.
Theo Ruers
Co-founder and CEO
-
Kudu Med develops ultrasound-based wireless power transfer technology for implantable medical devices. The company's platform enables safe, non-invasive recharging of implants such as pacemakers, supporting smaller devices, higher-power therapies, and reducing the need for replacement surgeries.
Yuval Shklarsh
Founder & CEO
-
Level Zero Health is building the world's first real-time access point to the next major data layer in healthcare: hormones. We are developing hormone monitoring wearables with clinical-grade accuracy, giving patients and clinicians access to biological data that has never existed before.
Ula Rustamova
CEO & Co-Founder
-
LifeShield Medical develops and manufactures cardiopulmonary support systems for critical care and high-risk cardiac interventions. Its ECMO system is approved and marketed in China and Hong Kong (CE-approval expected in Q3/Q4 2026). A mid-flow ECMO variant for moderate-to-severe COPD and a dedicated cannula set are pending regulatory approval in China and Europe in Q3/Q4 2026. The company's purge-free percutaneous ventricular assist device (pVAD) for high-risk PCI has successfully completed multiple initial human cases and entered its regulatory study in China. The company holds 50+ patents across R&D and manufacturing operations in Germany and China with 120+ team members.
Dr. Tim Kaufmann
Founder and Chairman
-
LIMIS has developed real-time, dye-free perfusion decision support for surgery.
Nils De Koff
Managing Director
-
Liquet Medical is developing catheter-based technology for the treatment of pulmonary embolism (PE). Our Versus™ Catheter combines bilateral pulmonary artery drug delivery with continuous, real-time pulmonary artery pressure monitoring through a single venous access, enabling physicians to assess hemodynamic response during catheter-directed thrombolysis.
John Schindler
Co-Founder & CEO
-
-small.webp)
Luminopia is pioneering a new class of treatments for neuro-visual disorders using virtual reality technology. The company's lead product has been FDA-cleared for pediatric amblyopia, the leading cause of vision loss in children worldwide. Since launch, the product has been prescribed to 14,000+ patients and is now being covered by major insurance plans including Anthem.
Scott Xiao
Co-Founder and CEO
-
LuSeed's DOME is a minimally invasive device for treating bifurcation and sidewall brain aneurysms simply and effectively. The device utilizes a braided mesh design that makes it position-agnostic within the aneurysm. Another benefit of the DOME device is its design, which minimizes protrusion to the parent artery, thereby mitigating the need for dual anticoagulation therapy.
Nitzan Hirsh
Co-Founder and CEO
-
MDA is building a best-in-class surgical reference database and translating the expertise of leading surgeons into advanced, AI-powered intra-operative decision-support solutions. Backed by €4 million in seed capital, MDA has successfully validated its business model over the past 24 months. To unlock the full potential of its approach and secure long-term market leadership, MDA is now seeking further growth capital.
Gunter Trojandt
Managing Director
-
-small.webp)
MedicubeX has developed a self-service eHealth Station™ that non-invasively measures key health markers in 5-10 minutes. Within the next 12 months the Stations start to accurately predict individuals' 10-year risk of developing heart disease or type 2 diabetes, completely without a blood test unlike anything on the market. By replacing needle pricks with simple, non-invasive health checks, it makes long-term disease prevention painless, fast, and accessible to everyone.
Vili Kostamo
Medical doctor, CEO, Co-Founder
-
Medividia accelerates medical-device development, testing and regulatory evidence generation by evaluating devices under physiological and patient-specific conditions or in virtual representations of standardized bench tests. Its numerical simulations capture interactions between blood flow, device and anatomy in applications including heart valves; LVADs, ECMOs; among others. These simulations complement bench, animal and clinical studies, supporting design decisions, patient selection and in silico clinical trials.
Deniz Ozturk
VP, In Silico Technologies
-
-small.webp)
Microsure develops MUSA-3, a CE-marked robotic system for open microsurgery and supermicrosurgery. The system scales and tremor-filters the surgeon's hand movements and works with standard microsurgical instruments, enabling procedures on vessels under one millimetre, such as lymphatic reconstruction for lymphedema.
Alex Joseph
Chief Executive Officer
-
Minze Health is a commercial-stage medical device and digital health company combining at-home uroflowmetry (Homeflow), automated bladder diary monitoring, and a digital therapeutic for BPH (Lutastic+) into a single connected platform, with its Minze app driving strong patient engagement through symptom tracking (IPSS, OABSS, voids, fluid intake). Backed by 27 publications and 150,000+ validated data sets, Minze replaces single-point clinical snapshots with longitudinal, real-world data across a combined ~$9.3B TAM in BPH and OAB. The company serves US and EU urology practices on an ARR model, with collaborations including Medtronic, Apogepha, and Coloplast.
Tom Moore
President & CEO
-
-(5)-small.webp)
Moximed is a commercial-stage medical device company offering the MISHA Knee System, an FDA-authorized Implantable Shock Absorber designed to treat medial knee osteoarthritis. The device is placed on the inner side of the knee during an outpatient procedure to absorb the impact of walking, reducing joint force by 30%. Differentiated by its joint-preserving design that does not require cutting bone, Moximed bridges the gap between conservative therapies and total knee replacement, offering active patients superior pain relief and mobility.
Christopher Gleason
President & CEO
-
Nano4Imaging develops MRI-compatible, MRI-visible interventional devices (e.g., guidewires) and AI-powered navigation software to enable catheter-based procedures under MRI guidance. The platform uses embedded marker technology and real-time image-based tracking to support device visualization and navigation while eliminating reliance on fluoroscopy and iodinated contrast.
Rudolf Schulze Vohren
Co-Founder and CEO
-
NeoCor develops the CoApt Valve®, a transcatheter device designed to treat severe mitral and tricuspid valve disease through a minimally invasive approach. The CoApt Valve features a self-expanding nitinol frame and an electrospun polymeric valve, aiming to reduce or eliminate regurgitant jets without the need for open-heart surgery. The device is delivered via a catheter inserted through the transfemoral vein, preserving the native valve structure. CoApt Valve is advancing its technology through preclinical studies in both canine and human models, with plans to initiate veterinary clinical trials.
George Kramer
Founder & CEO
-
Neuroelectrics unlocks the power of computational neuroscience to treat brain disorders—pioneering non-invasive tech for personalized neuromodulation, aiming to restore brain health & improve lives.
Ana Maiques
CEO & CoFounder
-
Neuroview Technology is a technologically proven medical device company that has developed a minimally invasive, implantable brain monitor. Our technology utilizes a brain-computer interface to continuously monitor brain state and fill a critical void in patient care necessary for better outcomes.
Scott Verner
CEO
-
NGScopes is a pre-clinical-stage medical device company based in Germany, developing a robotic instrument platform for endoscopy. NGScopes' instruments are independently steerable through the working channel of standard endoscopes, enabling precise, single-operator control without disrupting existing clinical workflows. The lead product, a robotic electrosurgical knife for endoluminal surgery, has demonstrated feasibility in ex vivo studies and is being prepared for FDA submission.
Jonas Steinhäuser-Meerz
CEO & Co-Founder
-
Nitinotes Ltd. is an early commercial-stage medical device company advancing endoluminal innovation for obesity care. Its flagship platform, EndoZip™, is the first fully automated, single-operator suturing system designed specifically for endoscopic sleeve gastroplasty (ESG). EndoZip™ is engineered to improve procedural workflow, support consistency, and enhance scalability of ESG while keeping physicians in control of technique and outcomes. The company received CE Mark approval in November 2025 and has initiated focused European commercialization, including its first commercial case in Italy. In the United States, EndoZip™ is an investigational device, currently being evaluated in the pivotal EASE clinical trial. Nitinotes is positioned at the intersection of metabolic intervention, procedural innovation, and growing global demand for minimally invasive obesity solutions.
Lloyd Diamond
CEO
-
Noah Labs Vox eliminates the no. 1 cause of hospital admissions - congestive heart failure - 3 weeks before hospitalization by analyzing voice changes caused by fluid build-up in the lungs and vocal tract. Trained on the world's largest heart failure voice data set, the patented technology is being piloted at Mayo Clinic, UCSF and Charité Berlin.
Leonhard Riehle, MD
Co-Founder & CMedO
-
-(7)-small.webp)
cMAP® is an AI-enabled PAP platform algorithm that predicts and prevents respiratory episodes before they occur. Its personalized approach delivers therapy at lower, more comfortable pressures — driving significantly better patient adherence.
Hamed Hanafi
CEO
-
NUA Surgical is a Galway-based maternal health medtech company focused on developing the SteriCISION C-Section Retractor, a disposable, self-retaining surgical tool designed to improve access, visualization, and ergonomics during Caesarean delivery while reducing surgical complications. The company's most recent funding was €6.5 million in Series A, led by EQT Life Sciences, to support manufacturing, testing, regulatory clearance, and early commercialization of the technology.
Barry McCann
CEO & Founder
-
Nuubo delivers patient-centric cardiac monitoring with textile-based, adhesive-free electrodes enabling comfortable 30-day wear, higher compliance, and continuous clinical-grade ECG data to improve detection and care decisions.
Juan Alcantara Morales
CEO
-
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat OSA. Nyxoah's lead solution is the Genio system, a patient-centered, leadless externally activated hypoglossal neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.
Olivier Taelman
CEO
-
OLI is a medical device company developing a platform for accessible, affordable kidney care. The company is building compact, low-cost systems to unlock clinical-quality hemodialysis and hemodiafiltration therapies for kidney failure patients from virtually anywhere.
Thomas Weindl
CEO & Co-Founder
-
_(24)-small.webp)
OSSTEC has developed a biomimetic 3D-printing platform for cementless fixation in orthopaedics. Its first product, ASCENT, is a cementless fixed-bearing partial knee system designed to streamline surgical workflow and expand the patients who can be treated with partial knee replacement.
Maxwell Munford
CEO & Founder
-
Osteoboost is the first and only FDA-cleared wearable therapy for osteopenia—clinically proven to reduce bone loss in the spine. Order online with prescription.
Laura Yecies
CEO
-
Oxford Cancer Analytics (OXcan) is an emerging diagnostics company that leverages advanced proteomics and machine learning to create innovative tests for earlier and more accurate assessment of lung diseases. OXcan partners with leading research and clinical institutions to accelerate the translation of laboratory breakthroughs into improved patient care.
Simon Meier
CEO
-
OxSonics is a clinical stage medtech company, spun out from Oxford University, specialized in oncology drugs delivery leveraging state-of-the-Art ultrasound technology and particles which together deliver more drugs into the tumor mass. Our flagship product SonoTran was used in a first In Man trial for treating liver metastasis in mCRC, was safe and able to generate positive early efficacy signals in terms of objective response of both on and off-target liver tumors.
Jerome Marzinski
CEO
-
PACATIS is building a personalised care platform for neurodevelopmental and neurocognitive disorders that transforms fragmented real-world data into predictive insights. By leveraging longitudinal monitoring and advanced analytics, the platform creates an individualised digital footprint that helps anticipate care needs, optimise care pathways, and facilitate earlier intervention.
Alexa Buck
Co-Founder
-
-(8)-small.webp)
Panda Surgical, a University College London spinout, is introducing the world's first robotics and AI platform for minimally invasive neurosurgery, offering surgeons enhanced dexterity and decision-support to make these operations safer, more effective, and more widely adopted.
Manios Dimitrakakis
CEO
-
Paradromics is building the world's most capable and clinically viable brain-computer interface (BCI) platform. Its advanced neurotechnology captures brain activity at the highest resolution, individual neurons, enabling AI-powered treatments for motor impairment, chronic pain, addiction, depression, and other neurological conditions. The company's first clinical product, Connexus® BCI, is designed to restore speech and communication for people who are unable to speak due to debilitating motor conditions.
Bill Marks
Chief Clinical Officer
-
PharmaSens is developing a fully integrated, automated insulin delivery platform that combines an insulin pump, continuous glucose monitor (CGM), and control algorithm into a single wearable device. The system is purpose-built to overcome current adoption barriers and unlock access to the ~80% of insulin-dependent patients not using pumps today.
Marcel Both
CEO
-
Knee+ NexSight brings AR-based guidance into the OR in a way that feels simple to learn, adopt, and to use. It does not ask surgical teams to reorganize around a large robotic system. It meets them where they are, with mobile guidance that fits into existing surgical environments and OR processes while helping surgeons validate alignment and execution in real time.
Kristoff Goson
CEO
-
Polimerbio is an early stage Medtech company dedicated to developing next generation biodegradable medical devices combining their knowledge on biomaterials and polymers science. The company has started its journey in the field of urology by developing the first intraurethral biodegradable stent for the management of urethral stricture after urethrotomy aiming at replacing the use of current non-biodegradable catheters.
Pablo Fernández
CEO
-
NeuroLF is a compact, dedicated brain PET imaging system designed to make high-quality neuroimaging more accessible and cost-effective. By combining advanced detector technology with a streamlined design, it enables earlier detection and monitoring of neurodegenerative diseases such as Alzheimer's Disesae in a wider range of clinical settings, including neurology offices.
Jannis Fischer
CEO
-
PreciPoint develops an IP-protected digital pathology platform that integrates high-performance imaging hardware with proprietary software and AI-driven workflows. The platform is designed for interventional pathology applications, including point-of-care use cases such as frozen sections (FS) and rapid on-site evaluation (ROSE), providing an end-to-end digital pathology solution.
Wolfgang Kintzel
Co-CEO & CSO
-
-small.webp)
EASEE is an innovative, evidence-based neurostimulation platform that offers a fully reversible, less invasive alternative to traditional treatments, reducing risks and side effects. Its first application in epilepsy care uniquely combines two therapeutic strategies to provide a safe, effective option for patients who have not responded to conventional therapies.
Karl Stoklosa
CEO
-
-small.webp)
Prenaital is developing a foundation model for maternal healthcare trained on millions of pregnancies. Our model is able to identify clinically relevant risks throughout the pregnancy, including the risk of preterm birth, from routine imaging. This enables early identification and intervention, to improve outcomes and reduce neonatal intensive care costs.
Tanja Danner
CEO & Founder
-
ProArc Medical is a clinical-stage urology company developing Omega, a novel dual-mechanism treatment for benign prostatic hyperplasia (BPH). Omega combines a controlled transurethral incision with a self-embedding Nitinol implant that provides durable mechanical retraction of the prostate. In an ongoing clinical pilot study, Omega has demonstrated significant and sustained improvement in BPH symptoms.
Gilad Hizkiyahu
CEO
-
Prolifagen is harnessing the power of microRNA to induce a proliferation of regenerative cells and help restore damaged tissues to a healthier functioning state. Their first application, called PRO302, is a patented mixture of miR302 and a hydrogel (Hyaluronic Acid) that is introduced to damaged heart tissue following a heart attack. The mixture induces a proliferation of cardiomyocytes, which can promote the regeneration of the patient's heart muscle as well as prevent the build-up of scar tissue. This can help restore the heart's pumping capacity and reduce the likelihood of progression to heart failure.
Michael Behr
CEO
-
Prometheus Therapeutics has developed the world's first Regenerative Photobiomodulation (PBM) platform to stimulate biologic healing. This is a patent-protected technology platform, and our first mission addresses the most significant unresolved clinical issue in Brain Aneurysm Care: awful long-term occlusion rates.
Chris Lear
Chief Strategy Officer
-
-small.webp)
Prothea Technologies is a private medical technology company developing a novel image-guided therapy and a vision of lung cancer biopsy and treatment in a single hospital visit.
Crispin Simon
CEO
-
Pulnovo Medical is a globally recognized device pioneer in the treatment for Group 1 & Group 2 pulmonary hypertension(PH) and heart failure. Our pioneer technology, PADN (Pulmonary Artery Denervation), is a first-in-class interventional therapy targeting overactive sympathetic nerves around the pulmonary arteries, supported by more than 1,000 clinical and commercial cases over the past decade. Pulnovo has obtained NMPA and EU MDR approval for Group 1 PH in 2023 and 2025 respectively, and has already commercialized the PADN products in China, EU, and Middle East. In 2025, Pulnovo received two FDA IDE approvals for PADN system clinical trials and is currently conducting multiple global clinical trials.
Mathias Bouzereau
Senior Business Development Director, International
-
QV Bioelectronics is developing GRACE, an implantable Tumour Treating Fields (TTF) device platform for treating solid tumours, initially focusing on glioblastoma (GBM). Placed during tumour resection surgery, GRACE delivers targeted TTF from within the body to disrupt cancer cell division, with an implantable design intended to maximise patient quality of life.
Carl Daintree
CEO
-
Core technology is a drug device combination: Bioelectricity with a medicinal substance that has proven to regenerate nerves, blood vessels, connective tissue as well as other tissues. The technology's NanoString transcriptomic profile revealed a robust activation of multiple gene expression pathways and has confirmed a profound molecular shift, with dozens of Nanostring biomarkers showing significant elevation after treatment. The technology is being deployed into the VA system Q4, 2026 as a stand-alone device (with drug) while the drug device combination will enter the Breakthrough therapy pathway late Q4, 2026.
Dr. Margaret Kalmeta
CEO
-
Today, a pregnant woman with contractions at night has to go to the hospital and go through invasive examinations to find out whether she is at risk of delivering early. With PremaSure®, her doctor gives her a first check she can do at home: the first self-test designed to help assess the risk of delivery in the next two weeks, as simple as a pregnancy test, with a result in 20 minutes, so together they can decide whether the trip is needed. Rea Diagnostics is running the first large-scale clinical trial of a home-based preterm birth test, in university hospitals in three countries, before CE marking and an FDA pathway.
Loulia Kassem
Co-Founder & CEO
-
ReLAAx Medical is developing an innovative solution for treating stroke risk in atrial fibrillation patients by restoring flow to the LAA. Our device is a shunt that is implanted percutaneously which leverages natural blood flow from an adjacent pulmonary vein to wash out the LAA. This novel approach avoids the persistent problems of thrombus and peri-device leak that plague other LAA therapies and allows patients to achieve their true goal - freedom from anticoagulation.
Rob Taft
CEO
-
ReNavie Sensing is the new novel technology focusing on mapping Renal Denervation and solving non responder issue.
Marcin Golebicki
CEO and Founder
-
Resivant Medical is commercializing a next-generation cyanoacrylate adhesive platform for surgical skin closure, based on a proprietary crosslinked silicone-cyanoacrylate chemistry designed to improve skin compatibility, mechanical performance, and ease of use for surgical teams. The platform represents a rare chemistry-level innovation in topical skin adhesives, combined with applicator and formulation improvements intended to enhance surgical workflow and clinical outcomes. These innovations address needs in a large and growing global skin closure market, valued at approximately $6.2B in 2024.
Darren Obrigkeit
CEO
-
RespirAq is developing a first-of-its-kind water-free active humidification system for respiratory care, designed to deliver effective humidification without an external water source. The technology aims to eliminate condensation and simplify respiratory circuits while reducing infection risk and clinical workload compared with conventional heated humidification.
Sandra Grau-Bartual
Founder & CEO
-
Respiree delivers a three-component platform combining a wearable FDA-cleared device, AI-powered deterioration detection software, and a care coordination enterprise-level platform. Together, these automate vitals collection, reduce alarm fatigue, and generate actionable clinical insights across inpatient and translational care settings.
Gurpreet Singh
CEO
-
Retia develops healthtech AI algorithms for helping guide management of surgical and critically ill patients to improve outcomes. This is a $4 billion market. The company's technology has been clinically validated and is used in 65 hospitals.
Marc Zemel
CEO
-
Revitalise develops a robotic microsurgical platform for ultra-precise retinal therapy delivery and for procedures beyond the reach of human dexterity. The platform is therapy-agnostic, aiming to be the delivery operating system for the next generation of retinal medicine, with a global market opportunity in the billions.
Christos Bergeles
Founder and CEO
-
RIVANNA® is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company's platform automates complex anatomical analysis at the point of care, enabling faster, more confident clinical decisions while reducing variability and expanding access to advanced capabilities. The first applications target significant market opportunities in regional anesthesia and fracture care.
Will Mauldin
CEO
-
-small.webp)
RSP Systems has developed the world's first non-invasive glucose measurement solution based on Raman spectroscopy and proprietary algorithms. We are developing a solution for tracking of glycemic health in people that do not have diabetes with FDA submission planned for second half of 2028. Our technology is capable of identifying multiple analytes in the skin and the application space thus goes beyond glucose.
Michael Gürtler
Chief Commercial Officer
-
Samay’s Sylvee is the first wearable to match CT performance, the gold standard, for early COPD detection, identifying small airway disease up to 5 years before spirometry can detect any changes. Validated in 450+ patients (AUC 0.93) and protected by 18 patents across 20+ countries, Samay is already generating revenue with a top European respiratory pharma, a world-leading sleep company, and a top US academic medical center, while preparing for a late 2027 launch across 1,500 clinics through Latam’s third-largest payer and investor.
Maria Artunduaga
Founder & CEO
-
Sealantium's sFilm-FS is a transparent, flexible, biodegradable co-polymer film combined with human fibrinogen and thrombin, used as a hemostatic and sealing patch in both open and minimally invasive/robotic surgery. Current target indications include cardiovascular, liver, neurosurgery (dura sealing), GI tract/anastomosis, and lung resections.
Jay Kapoor
Business Development Lead
-
The critical bottleneck of healthcare AI and drug development was access to data; Segmed spent seven years solving that problem starting with medical imaging, resulting in the leading multimodal clinical data network, with 31M+ patients, 150M+ imaging exams, and a foundation already validated by 50+ FDA customers clearances. The next decade belongs not to those who move data, but to those who generate intelligence from it, which is why Segmed is extending from data delivery to AI-driven insight delivery across imaging, clinical notes, pathology, and beyond. This transition expands our addressable opportunity from real-world imaging data for AI-development to multi-modal real-world evidence for drug development and medical AI.
David Gascoigne
CEO
-
SmartValves is developing next-generation technology for heart valves by adding a “brain” to what is currently a passive implant. Our platform is designed to enable active EGM sensing and on-demand pacing, with the potential to meaningfully impact both patient care and the healthcare system. Our initial focus is the TAVR market, where these capabilities may support: Systematic, Safe next-day discharge, helping patients return to normal activity sooner while supporting hospitals in optimizing capacity.Meaningful reduction in permanent pacemaker implantation, through proactive monitoring and mitigation of conduction disturbances associated with TAVR.Beyond TAVR, we believe the SmartValves platform can extend to tricuspid and other structural heart therapies, significantly broadening its clinical and commercial potential. At the same time, continuous EGM acquisition creates a unique data layer that, combined with AI-driven analytics, may enable earlier detection and prediction of clinically meaningful events, expanding SmartValves from a therapeutic device into a connected patient-management platform.
Chaim Lotan
Chief Innovation Officer
-
-(9)-small.webp)
Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants.
Bart Bandy
Chief Executive Officer
-
Sonata Medtech harmonizes the PFA ablation procedures with a 3rd generation pulse generator and catheter. Large inflexible carts, disliked universally by the EP Labs, are eliminated and replaced with a permanently mountable small box with industry leading output control and flexibility. Multiple catheters can be reduced to a single catheter by Sonata that can do many types of arrhythmias without mid-procedure catheter changes.
David Jacques
CEO
-
-small.webp)
SpotLab.ai builds mobile, efficient and sovereign AI to upgrade millions of existing microscopes into intelligent tools for diagnosis and clinical research. Its technology helps clinicians detect subtle patterns in microscopy images using equipment they already have, expanding access to the best healthcare for everyone, everywhere: from blood cancers to neglected tropical diseases.
Miguel Luengo-Oroz
CEO & Founder
-
STENTiT is developing the Resorbable Fibrillated Scaffold (RFS), a novel class of regenerative implants, solely composed from resorbable fibers. The balloon expandable implant provides instant structural support to keep the artery open, while allowing circulating blood cells to infiltrate into the porous mesh. This triggers a natural healing response by which immune cells gradually replace the mesh with new vascular tissue as the implant safely dissolves over time. Hereby, the RFS fully reconstructs the artery from the inside out. In addition, the fibrillated design allows to be scaled beyond 100 mm to serve the majority patient population.
Bart Sanders
CEO & Founder
-
Surgerix develops software that integrates real-time multi-camera video feeds into operating room systems during neurosurgery and ENT procedures. The platform provides synchronized visualization for surgeons, supports intraoperative documentation and clinical training programs for microsurgery. Our solution integrates with existing microscope and exoscope hardware from major manufacturers. Currently we are entering clinical validation.
Mikko PItkänen
CEO
-
Surgical Reality converts routine diagnostic CT scans into patient-specific, interactive 3D models. Thoracic surgeons and interventional pulmonologists use the software for pre-operative resection planning and for intra-operative guidance during lung cancer surgery and bronchoscopic interventions. The platform is CE marked under MDR (Class IIa) and FDA 510(k) cleared, and is in clinical use in hospitals in the Netherlands, Germany, Belgium, Australia, Switzerland, Norway and United Kingdom.
Chris Hordijk
Founder/CEO
-
Tensive is a clinical-stage biomaterials medical device company developing innovative bioresorbable scaffolds for breast reconstruction and tissue marking. Its patented REGENERA and SOFTAG scaffolds are designed to allow regeneration of the body's own tissue to create natural, safe and lasting reconstruction for patients recovering from lumpectomy or during cosmetic procedures. The result is restoration that preserves the original shape and feel of the patient's breast, yet is clearly differentiated from surrounding tissues on imaging.
Sanjay Kakkar
CEO
-
-small.webp)
TheraBionic is a first‑in‑class, FDA‑approved medical device that delivers low‑intensity, amplitude‑modulated radiofrequency electromagnetic fields to treat advanced liver cancer. Its non‑invasive mechanism targets tumor metabolism and signaling pathways, offering a safe, well‑tolerated therapy that can be used alone or synergistically with systemic treatments.
Boris Pasche
Co-founder and Member
-
Theraclion develops Sonovein®, a robotic HIFU platform that enables varicose veins to be treated fully non-invasively from outside the body, without catheter, incision, tumescent anesthesia, or operating room infrastructure. By combining real-time ultrasound imaging, robotics, and automated treatment planning, Sonovein® precisely targets and thermally closes diseased veins, creating a new treatment category beyond conventional endovenous ablation. The company is entering a scale-up phase, with commercial acceleration in Europe and the Middle East, pending regulatory submissions in the U.S. and China, and continued technological improvements to the Sonovein® platform.
Martin Deterre
CEO
-
Tulyp Medical is developing a pressure-guided limb perfusion system for patients experiencing reduced or disrupted blood flow to the lower limb during cardiovascular procedures. The system combines a pressure-sensing catheter with a compact pump to monitor limb perfusion and actively regulate blood delivery, with the goal of reducing the risk of procedure-associated acute limb ischemia.
Steve Motes
CEO
-
-small.webp)
Utilizer has developed the first rapid, ultra-low-cost near-patient solutions for urinary tract infection testing. Its proprietary Utilizer-ID® platform is designed to provide lab-accurate pathogen identification, and antibiotic susceptibility in a streamlined workflow, delivering actionable microbiological information at the point of care. By enabling fast and informed treatment decisions, Utilizer aims to improve patient outcomes, reduce the 60% unnecessary antibiotic use, and support antimicrobial stewardship in a growing global diagnostics market.
Sofia Bertling
CEO
-
Vascudyne develops off-the-shelf bioengineered vascular and heart valve devices designed to regenerate into living cardiovascular tissues through host cell integration and remodeling. The platform targets major unmet needs in coronary, congenital, and structural heart disease by providing durable long-term solutions.
Zeeshan Syedain
CEO
-
Vergent’s lead compound, abenacianine for injection (VGT-309), is a next generation tumor-targeted fluorescent imaging agent for cancer surgery designed to provide real-time, intraoperative visual and molecular feedback on tumor location and help surgeons ensure all tumor tissue is removed during minimally invasive surgery (MIS) procedures. Abenacianine is designed to be an ideal targeted imaging agent and is compatible across NIR enabled surgical visualization platforms, works across all solid tumor types, and has a differentiated mechanism of action that allows for a wide dosing window to seamlessly fit into surgery workflows.
Adam Gridley
CEO
-
Versono is developing an intravascular ultrasonic platform to improve the crossing of severe occlusions in the peripheral vasculature. The device will prepare a working lumen to support endovascular therapy in patients with chronic total occlusions (CTOs) and critical limb ischemia (CLI).
Finbar Dolan
CEO
-
-small.webp)
Vivifi Medical is pioneering the first non-surgical, non-urethral device for treating BPH that targets the hormonal root cause rather than simply managing symptoms. By redirecting testosterone-rich blood away from the prostate, our approach results in true regression without implants, urethral instrumentation, or compromise to sexual function.
Tushar Sharma, PhD
CEO & Founder
-
WISE is a medical device company developing neural electrodes for neuromonitoring, neuromodulation, and brain-machine interfaces, based on its proprietary Supersonic Technology, which embeds conductive layers within soft, ultra-thin silicone to produce stretchable, conformable electrodes that adhere closely to neural tissue. Its portfolio includes the WISE Cortical Strip (WCS®), a CE-marked, FDA-cleared, and TGA-approved electrode that conforms to the cortical surface for intraoperative neurophysiological monitoring, and the Heron® lead, a directional multicolumn lead for chronic pain treatment, delivering paddle-like spinal cord stimulation percutaneously, without a laminectomy, and currently preparing for clinical validation.
Luca Ravagnan
CEO
-
-(26)-small.webp)
Xeltis is a commercial-stage medtech company developing transformative implants that enable the natural creation of living and long-lasting vessels to address the limitations of current treatment options for the millions of patients requiring hemodialysis vascular access or cardiovascular replacements every year. The Company’s proprietary Restorex® platform utilizes an advanced polymer implant which is transformed into the patient’s own tissue before gradually being absorbed and leaving new, living vessels in place that support long-term clinical outcomes. Its most advanced product aXessTM, an implantable blood vessel for hemodialysis vascular access, has received CE Mark approval and is now being commercially deployed across Europe. Xeltis aims to improve patient outcomes by enabling the creation of living vessels to reduce the need for repeat interventions and address significant unmet needs in vascular access. The Company’s groundbreaking technology also has high potential to be applied to other major vascular and cardiovascular diseases.
Eliane Schutte
CEO
-
YOPI has developed a proprietary wearable device, worn on the upper arm, that continuously analyzes sweat to monitor key physiological electrolytes and metabolic markers in real time. The technology enables early identification of cardiovascular risk indicators—well before clinical symptoms appear, while delivering advanced performance insights, including real-time oxygen consumption (VO₂), accurate calorie expenditure, and substrate utilization (fat, carbohydrates, and proteins), along with additional critical physiological metrics. This non-invasive platform replaces traditional offline VO₂ testing and intermittent blood-based diagnostics with continuous, real-time, and clinically relevant health monitoring—effectively bringing the metabolic lab into everyday life.
Menachem Genut
Co-Founder & Chief Scientific Officer
inspirational
voices to the
conversation
